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Abstract 
Aortic stenosis and athrosclerosis are slowly progressing diseases. Being clinically silent, as they start 
developing decades before they cause symptoms, cardiovascular diseases and atherosclerosis in particular, 
are the leading cause of morbitidy and mortality in the Western world. Lipid accumulation begins both in the 
artery walls and in the aortic valves before any clinical signs of atherosclerosis or aortic stenosis can be 
detected. While atherosclerotic lesions are characterized with cells filled with lipid droplets i.e. foam cells, 
and they are found to be calcified only in the late stages of atherosclerosis, the stenotic aortic valve leaflets 
contain both lipid droplets and calcified nodules already in early lesions. The proteoglycan matrix common 
to artery wall and aortic valve leaflets retains the entering lipoprotein particles that are then enzymatically 
and oxidatively modified. Such modifications have an ability to transform the non-inflammatory plasma 
lipoprotein particles into crystals and particles that can induce sterile inflammation in the various intimal and 
valvular cells.  
This thesis was set to study the distribution and characteristics of the extracellular lipid and to reveal the 
origin of the extracellular lipid particles. Prior to the analyses of the isolated extracellular lipid particles, the 
human carotid artery plaques were imaged with three-dimensional electron microscopy and sections of 
human coronary arteries were analyzed with imaging mass spectrometry to study the spatial distribution of 
lipids in different stages of atherosclerosis. In the human coronary arteries, the lipid domains found in 
advanced atherosclerotic lesions were different from the domains found in atheroma-stage artery sections, 
and even more different from healthy sections of coronary arteries. In the human carotid artery plaques, 
cholesterol crystals were found to be large sheets or needle-like structures, and they appeared to be growing 
out from large lipid particles in the intima. For the purpose of studying the chemical and physical 
characteristics of the extracellular lipid particles, the extracellular particles were isolated from aortic valve 
leaflets and coronary artery plaques. The lipid particles were examined with multiple tools to study their lipid 
composition, protein composition, protein structure, size, and density. The extracellular lipid particles, both 
in human aortic valve leaflets and human carotid arteries, were found to be derived from plasma lipoproteins, 
mainly from low density lipoprotein (LDL) or very low density lipoprotein (VLDL). Apart from multiple 
small exchangeable lipoproteins, like apolipoprotein (apo) E, apoA-family, and apoC-family, the particles 
contained mainly apolipoprotein B-100 (apoB-100), the integral protein of LDL and VLDL, and they 
contained features which suggest that they were multiply modified. Another goal was to find which 
modifications would change the intimal or valvular extracellular lipid particles to such fused and aggregated 
lipid particles that were found in the valves and intimal plaques, and which modifications would induce a 
sterile inflammatory response similar to the response the extracellular lipid particles induce. To study the 
possible culprit modifications, both the extracellular lipid particles, in vitro-generated cholesterol crystals, 
and LDL that was modified by lipolysis, proteolysis, and oxidation, were applied to human primary 
monocyte-derived macrophages. Both the isolated extracellular lipid particles and LDL modified with a 
combination of phospholipolysis by PLA2 and cholesterol esterase were found to be able to activate a 
multiprotein complex inflammasome in human primary monocyte-derived macrophages in vitro, and to 
induce the secretion of proinflammatory cytokines. 
According to the results of this thesis, the lipid particles in the arterial intima and in the aortic valve are 
active components of atherosclerosis and aortic stenosis. They can induce the cells in the intima and in the 
valve to produce inflammatory cytokines and thus can affect the progress of these diseases.  
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Tiivistelmä 
Aorttastenoosi eli aorttaläpän kalkkinen kovettumatauti ja ateroskleroosi eli valtimokovettumatauti ovat 
hitaasti eteneviä tauteja. Koska nämä sydän- ja verisuonitaudit kehittyvät piilossa oireita aiheuttamatta jopa 
vuosikymmenten ajan, ne ovat yhä edelleen suomalaisten ja läntisen maailman kuolinsyytilastojen kärjessä. 
Lipidit eli rasva-aineet alkavat kertyä sekä aorttaläppään että valtimoiden seinämään jo paljon ennen kuin 
mitään kliinisiä merkkejä on havaittavissa. Ateroskleroosissa plakit ovat tyypillisesti täynnä 
rasvapartikkeleita eli lipidipartikkeleita ja soluja, jotka ovat täynnä rasvapisaroita (vaahtosoluja) ja ne 
kalkkiintuvat vasta taudin myöhäisvaiheessa. Aorttaläpissä on sen sijaan yhtä aikaa sekä lipidipartikkeleita ja 
kiteytynyttä kalkkia. Sekä aorttaläpässä että valtimon seinämässä on proteoglykaanikerros, johon 
lipidipartikkelit tarttuvat kiinni. Kiinni tarttuneet lipidipartikkelit voivat voivat muokkaantua entsyymien 
vaikutuksesta tai hapettumisen seurauksena. lipidipartikkelien muokkaantuminen voi saada aorttaläpän tai 
valtimon sisäkerroksen solut reagoimaan steriilillä tulehdusreaktiolla tai muokkaantuneet lipidipartikkelien 
sisältämä kolesteroli voi kiteytyä suuriksi kolesterolikiteiksi. 
Tässä väitöskirjassa tutkittiin solunulkoisten lipidipartikkeleiden ominaisuuksia ja niiden levittäytymistä 
solujen väliseen tilaan. Siten pyrittiin selvittämään solunulkoisten lipidipartikkeleiden alkuperä. Ihmisen 
kaulavaltimoiden seinämästä valmistettiin malleja kolmiulotteisten elektronimikroskooppikuvien avulla ja 
ihmisen sepelvaltimoleikkeitä tutkittiin kuvantavalla massaspektrometrilla. Näin saatiin selville, kuinka 
lipidipartikkelit sijaitsivat valtimoiden seinämässä. Terveiden sepelvaltimoiden lipidipartikkelikertymien 
laatu ja paikka erosivat aterooma-vaiheen plakkien lipidipartikkelikertymistä ja vielä enemmän ne erosivat 
pitkälle edenneestä ateroskleroottisesta plakista. Ihmisen kaulavaltimoiden plakeissa kolesterolikiteet olivat 
sekä neulamaisia että suuria levyjä ja ne näyttivät kasvavan suoraan suurista lipidipartikkeleista. 
Kemiallisten ja fysikaalisten ominaisuuksien selvittämiseksi lipidipartikkelit eristettiin sekä aorttaläpistä että 
kaulavaltimoista. Niistä tutkittiin lipidikoostumusta, proteiinikoostumusta, proteiiniosan rakennetta, 
partikkelien kokoa ja tiheyttä. Sekä aorttaläpän että kaulavaltimon lipidipartikkeleiden havaittiin olevan 
peräisin plasman apolipoproteiini (apo)B-100:aa sisältävistä lipoproteiinipartikkeleista, todennäköisimmin 
joko kevyen lipoproteiinin (LDL) tai erittäin kevyen lipoproteiinin (VLDL) partikkeleista. Partikkelit 
sisälsivät apoB-100:n lisäksi myös pieniä vaihdettavia apolipoproteiineja, kuten apolipoproteiini (apo) E:tä, 
apoA-proteiiniperheen ja apoC-proteiiniperheen apolipoproteiineja. ApoB-100 (LDL:n ja VLDL:n tärkein 
rakenneproteiini) oli yleisin löydetty proteiini. Lipidipartikkeleissa nähtiin merkkejä moninkertaisesta 
muokkautumisesta.  
Tutkimuksen toisena tavoitteena oli saada selville, miten aorttaläpän ja valtimon sisäseinämään jääneet 
lipidipartikkelit muuntuvat plasman lipoproteiineista suuriksi fuusioituneiksi ja aggregoituneiksi 
lipidipartikkeleiksi. Lisäksi haluttiin tietää, mitkä muokkausmekanismit muuntaisivat lipoproteiinit niin, että 
solut reagoisivat steriilillä tulehdusreaktiolla eli inflammasomi-kompleksin aktivaatiolla. Mahdollisia 
muuntumismekanismeja tutkittiin muokkaamalla LDL-partikkeleita lipolyyttisillä ja proteolyyttisillä 
entsyymeillä ja hapettamalla niitä. Näin muokattuja LDL-partikkeleita ja kaulavaltimoista eristettyjä 
lipidipartikkeleita annettiin ihmisen plasmasta eristetyistä monosyyteistä erilaistetuille makrofageille. Sekä 
solunulkoiset lipidipartikkelit että fosfolipolyysillä muokatut plasman lipoproteiinit saivat koeolosuhteissa 
makrofagit reagoimaan inflammasomin aktivaatiolla ja tuottamaan tulehdusvälittäjäaineita.  
Väitöskirjan tulosten mukaan voidaan todeta, että lipidipartikkelit aorttaläpässä ja valtimon sisäseinämässä 
ovat oleellinen osa aorttastenoosin ja ateroskleroosin syntyprosessissa. Ne saavat aorttaläpän ja valtimon 
sisäseinämän solut tuottamaan tulehdusvälittäjäaineita ja vaikuttavat siten sekä aorttastenoosin että 
ateroskleroosin etenemiseen.  
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Introduction 
Cardiovascular diseases continue to be the largest cause of morbidity and mortality in Western world. Since 
1950's, the mortality rates to cardiovascular diseases have been declining (WHO, 2010). Still, since the 
recognition of cholesterol as one of the main culprits, serum cholesterol levels have declined only slightly 
(Farzadfar et al., 2011), but cardiovascular diseases remain the major cause for morbidity (WHO, 2015). As 
the process in the arteries leading to atherosclerosis may be more complex than the simple accumulation of 
cholesterol-containing particles, we still have several details to clear.  
Atherosclerosis and aortic stenosis are two different diseases in the same system, yet the major risk factors of 
both diseases are shared: smoking is found to worsen both conditions, old age, and male sex, or rather lack of 
estrogen, hyperlipidemia, hypertension, and diabetes are in the long list of risk factors of both diseases 
(Hansson, 2005; Lindroos et al., 1994; Rajamannan, 2009). Both diseases are also linked with lipid 
accumulation in the extracellular matrix. While cholesterol is considered the most important risk factor in 
both atherosclerosis and aortic valve disease, lowering of plasma cholesterol with statins alleviates 
atherosclerosis, but has no significant effect regarding progression of aortic stenosis (Rossebo et al., 2008). 
In atherosclerosis, if plasma cholesterol is lowered to a level low enough (by 1 mmol/l), already developed 
plaques start to regress (Puri et al., 2015). In contrast to that, already stenotic aortic valves do not become 
less stenotic even if the plasma cholesterol level is intensively lowered with combined use of a statin and 
ezetimibe (Rossebo et al., 2008).  
Both in atherosclerosis and aortic stenosisthe disease initiates when cholesterol-containing lipoproteins 
accumulate in the subendothelial extracellular matrix of the arterial system, i.e. in the subendothelial matrix 
of the arterial intima or of the aortic valve, respectively. Arteries as well as aortic valves contain 
proteoglycans (Della Rocca et al., 2000; Wight and Ross, 1975a; Wight and Ross, 1975b), that act as 
cushions against pressure surges of the blood flow. In this dense proteoglycan matrix lipoproteins attach and 
accumulate (Williams and Tabas, 1995) as extracellular lipid particles (Guyton and Klemp, 1989; Pasquinelli 
et al., 1989). The retained lipoproteins can become modified by the lipolytic, proteolytic, and oxidative 
enzymes and agents that the local cells secrete, and the modified lipoproteins can then be avidly taken up by 
macrophages to form lipid-filled foam cells. The modified lipid particles are also a source of cholesterol 
crystals, which are a recognized activator of a multiprotein complex called inflammasome (Rajamäki et al., 
2010). Inflammasome is activated by several different factors, such as by the aforementioned cholesterol 
crystals, as well as by monosodium urate crystals (Martinon et al., 2006), asbestos (Sayan and Mossman, 
2016), extremely fine carbon particles (Murphy et al., 2012) acid pH (Rajamäki et al., 2013) and the acute 
phase protein SAA (Niemi et al., 2011).  
The aim of this thesis work was to characterize the extracellular lipoproteins and lipid particles in human 
atherosclerotic arterial intima and in human stenotic aortic valves, and to compare them with plasma 
lipoproteins and the lipids contained in them. This study also aimed to study different modifications which 
have affected the lipoprotein particles, and to find how and why extracellular lipid particles have been 
formed, and what kind of an effect the extracellular lipid particles may have on atherosclerosis. The spatial 
distribution of lipids in different stages of atherosclerosis was also studied together with the microstructure 
of the extracellular lipid particles and cholesterol crystals in a carotid artery plaque. As cholesterol crystals 
have been found to be a strong inflammasome activator in human (Rajamäki et al., 2010) and mouse 
(Duewell et al., 2010) macrophages, also the effect of extracellular lipid particles on human primary 
macrophages was studied.  
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Review of the literature 
Normal aortic valve and arterial wall 
Aortic valve 
 
 
 
 
 
 
 
 
Aortic valve (Figure 1) is one of two semilunar valves of the heart, and is situated in the aortic root, between 
left ventricle and aorta, and it is attached to connective tissue ring, annulus (Misfeld and Sievers, 2007). The 
valve is normally formed of three cusps, but occasionally only two cusps are found. Rarely one or four, or 
even five cusps are found (Roberts and Ko, 2005; Schmidt et al., 2008). On the aortic side, the cusps and 
aortic root form sinus of Valsalva, a bulging structure in the beginning of aorta, from where the coronary 
arteries begin. Aortic valve prevents reflux of blood after the heart has pumped blood into the aorta, 
maintaining one-way flow of blood (Misfeld and Sievers, 2007). 
Valvular spongiosa, ventricularis, and fibrosa 
 
 
 
 
 
 
 
Aortic valve leaflets are extensions of endocardium and formed from an endocardial fold (de Lange et al., 
2004; Hinton et al., 2006), covered by endothelium on its both sides. Endothelium of the valve differs from 
endothelium of an artery (Deck, 1986). In the valve, endothelial cells are aligned perpendicularly against 
blood flow, and they produce vasoactive substances that bring the myofibroblasts of the valve to contract 
when the endothelium is intact (Deck, 1986). Three separate layers can be found in the aortic valves leaflets: 
Figure 1. Aortic valve. Aortic valve 
consist of three cusps that are supported 
by a connective tissue ring, annulus. 
Coronary arteries have their origins 
from two of the cusps. (Gray, 1918), 
plate 497. (Schönherr et al.) (PD-Art) 
Public Domain 
 
Figure 2. A schematic drawing of a 
healthy aortic valve. Aortic valve 
consists of endothelium and three 
layers: fibrosa (on the aortic side), 
spongiosa, and ventricularis (on the 
ventricular side of the valve). 
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fibrosa on the aortic side, spongiosa in the middle, and on the ventricular side of the valve, ventricularis 
(Figure 2). Fibrosa, has collagen fibers that are perpendicular to the elastin fibers of the ventricularis (Scott 
and Vesely, 1995) They offer support to the valve leaflets, as blood flow on the aortic side is turbulent. 
Fibrosa consists of myofibroblasts that contain both vimentin and smooth muscle actin (Della Rocca et al., 
2000). (Latif et al., 2005; Stephens, Chu, and Grande-Allen, 2008). Myofibroblasts secrete collagen, and 
proteoglycans, which will be discussed in a later chapterpage 19. Fibrosa can be as thin as some cell layers. 
Spongiosa, the second layer in between ventricularis and fibrosa, is sponge-like and soft, containing 
fibroblasts, mesenchymal cells, and extracellular matrix (Della Rocca et al., 2000). Ventricularis consists of 
fibroblasts and elastin fibers the cells secrete (Della Rocca et al., 2000), and valvular interstitial cells (VIC) 
that have both fibroblast and smooth muscle cell features (Filip, Radu, and Simionescu, 1986). Ventricularis 
has also proteoglycans to even the pressure and stretch due to blood surge against the valve, and the total 
proteoglycan content is higher than in spongiosa or fibrosa (Stephens, Chu, and Grande-Allen, 2008). VICs 
are found also in other layers, as they are arranged in net-like structure around valvular leaflets. 
Arteries 
Arteries are blood vessels that carry oxygenated blood from the heart to the periphery (Figure 2). As the 
heart creates varying pressure conditions in aorta and in the largest arteries, they require special adaptations. 
Arterial walls of the aorta and largest arteries receive the systolic pressure surge and dampen the force of the 
pulse as the flexibility of the arterial wall suppresses the pressure, thus their walls are thick and elastic. 
Blood pressure drops in the small arteries, and in the arterioles, blood flow is almost laminar. 
Aorta 
Aorta is the largest artery and it carries blood flow to the systemic circulation (Figure 3A). It starts from the 
aortic valve and ascending aorta. The first branches are the left and right coronary arteries, supplying the 
heart muscle. From the aortic arch the branches supply the arterial circulation of the neck, head and upper 
extremities: right the brachiocephalic trunk from which the right common carotid artery and the right 
subclavian artery originate and left the common carotid artery and the left subclavian artery which originate 
in the aortic arch. The descending aorta and the abdominal aorta branch out to supply the bronchus and the 
esophagus and the thoracic cavity, and the organs in the abdomen and the pelvic area, respectively. Aorta 
ends in a bifurcation which branches into iliac arteries for the lower limbs. Walls of the aorta are thick and 
elastic to compensate the pressure surge of the heart.  
 
 
 
 
 
 
 
 
 
Figure 3. Thoracic aorta and its 
branches, and the right carotid 
artery A. Aorta is the largest 
artery and it begins after an aortic 
valve from the left atrium of heart. 
Coronary arteries start from cusps 
of the aortic valve and they carry 
blood to a heart muscle. Carotid 
arteries (B) branch from the aorta 
and carry blood to head. (Gray, 
1918), plate 505, plate 513. (PD-
Art) Public Domain 
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Coronary arteries 
Coronary arteries aorta (Figure 3A) emerge, from inside of cusps of the aortic valve (Figure 1) called sinuses 
of Valsalva, and they supply oxygen and nutritients to the heart muscle. (Villa et al., 2016). The largest 
coronary artery is the short left main coronary artery. (Olivier et al., 2012). The left main coronary artery and 
its branches (left anterior descending artery and left circumflex artery (LCx) supply blood to the left ventricle 
and the left atrium, while the right coronary artery (RCA) branches supply blood to the right ventricle and 
atrium. Posterior descending artery and posterolateral artery are branches of either the RCA or LCx, and thus 
determine the dominance of the coronary artery system (Kini, Bis, and Weaver, 2007). In the right 
dominance system RCA sypplies the inferior segment of the left ventricle as well as the inferoseptal segment 
of the left ventricle, and this is more common (80—85 % of the cases) than the left dominance, in which 
LCx is the supplying vessel (Kini, Bis, and Weaver, 2007). The main branches of the coronary arteries may 
also be connected to each other and form collaterals that can provide blood supply to the the heart muscle in 
case of occlusion of the other branch (Werner, 2014). The lumen diameters of coronary arteries close to the 
aortic valve are the largest and become narrower branch by branch. (Dodge et al., 1992).  
Carotid arteries 
Common carotid arteries (Figure 3B) are large branches of aorta on the left and brachiocephalic artery on the 
right, on either side of the neck. They carry blood to the head and cranium. Common carotid artery (CCA) 
bifurcates into internal carotid artery (ICA) and external carotid artery (ECA). ECA branches to provide 
circulation to extra-cranial part of head. ICA supplies blood flow to intracranial arteries. It branches into 
several sections, which include ophthalmic artery and an artery ring that branch into cerebral arteries (Circle 
of Willis). 
Structure of the arteries  
 
 
 
 
 
 
 
 
 
 
 
The basic structure is similar in all arteries (Figure 4). In every artery there is an endothelial cell layer where 
the endothelial cells line the lumen to contain the blood flow inside of the artery. Under the endothelial cells 
and a basal lamina, there is loose connective tissue. An elastic layer, internal elastic lamina, is the border 
between intima and media. Media consists of smooth muscle cells and fenestrated elastic plates or laminae. 
Figure 4 Basic structure of an artery. The basic structure of an artery consists of intima, media and 
adventitia. The intima consists of the endothelium and internal elastic lamina. A dense internal elastic 
lamina separates intima from media, and only small particles such as high density cholesterol can cross it. 
Media is nourished by vasa vasorum that originate from the adventitia and drained by lymphatic vessels, 
that also come from the adventitia.  
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Between adventitia and media, there is an external elastic lamina. (Figure 4) External elastic lamina separates 
the media from adventitia, which consists of loose connective tissue.  
In small arteries, where the hemodynamic forces and wall tension are low, the intima can be very thin, 
consisting only of the endothelial cells and the internal elastic lamina (Stary et al., 1992). In the large 
arteries, however, where the dampening of the pressure surges are necessary, the layer between the 
endothelial basal lamina and internal elastic lamina thickens into cushioning and energy-compensating 
proteoglycan-rich intima (Stary et al., 1992). The luminal side of normal intima is rich in proteoglycans, a 
thick net-like mesh. The proteoglycans, containing a core protein to which glycosaminoglycans such as 
dermatan sulfate, chondroitin sulfate and hyaluronic acid are attached to, are secreted by intimal smooth 
muscle cells (Wight and Ross, 1975a; Wight and Ross, 1975b). Internal elastic lamina is a dense mesh-like 
mat of elastic fibers, in which there are small holes called fenestrations (Kwon et al., 1998). It isolates the 
intima from the media, so that only smallest particles like high density lipoprotein (HDL) and intimal fluid 
are able to pass through (Kwon et al., 1998; Smith, 1990). Some areas, however, like bifurcation curvatures 
and branches, lack a well-defined internal elastic lamina (Stary et al., 1992). No blood vessels or lymphatic 
vessels are found in a healthy intima. The cells are only fed with nutrients and oxygen by diffusion from the 
blood stream in the lumen.  
Outwards of the internal elastic lamina, there is a layer of smooth muscle cells, tunica media. In the small 
arteries it can be only one layer of smooth muscle cells while in the large arteries it consists of several layers 
of smooth muscle cells and elastic laminae. Medial smooth muscle cell layer provides arteries their ability to 
stretch and contract and thus maintain the arterial tonus. The smooth muscle cells are circumferentially 
arranged to surround the lumen, and between them there are elastin fibers. On the outer border of media 
external elastic lamina separates media from adventitia. Adventitia (300-500 μm thick, (Waller et al., 1992)) 
consists of elastic fibers and unorganized connective tissue. It serves to attach the arteries into tissues while it 
also contains specific blood vessels, nerves and lymphatic vessels to nourish and drain the arteries 
themselves. The lymphatic vessels and vasa vasorum reach only the media (Michael Munro and Path, 2012).  
 Lipoproteins 
 
 
 
 
 
 
 
 
Lipoprotein particles transport nonpolar lipids in the blood stream. The lipoprotein particles consist of a 
protein moiety, a single layer phospholipid surface and a core containing nonpolar lipids (Figure 5). Next, 
lipoproteins will be discussed.  
Figure 5. A schematic picture of the structure of an apoB--containing lipoprotein.  
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Proteins in chylomicrons, VLDL, IDL, LDL, and HDL 
ApoB-48 and apoB-100 are structural proteins with which the lipids are incorporated in the particle. There is 
only one ApoB-48 or apoB-100 in a particle. They are integral proteins, which only gain their proper 
conformation when bound to lipid (Fisher, Lake, and McLeod, 2014). ApoB-48 found in chylomicrons is an 
intestinal splice variant product of apoB-100 gene, containing the N-terminal 48 % of the apoB-100 protein, 
where the name is derived from (Chen et al., 1987). ApoB-100 is the integral protein of VLDL, IDL, and 
LDL. ApoB-100 contains 4536 amino acids, the calculated mass of its unglycosylated form is 512 000 Da, 
making it one of the largest monomeric proteins (Knott et al., 1986; Law et al., 1986; Scott et al., 1987). 
When fully glycosylated, the protein's molecular weight is 550 000 (Cardin et al., 1984; Swaminathan and 
Aladjem, 1976). Its has approximately 40 % α -helix, 20 % β-sheet, and 20 % random structures (Chen et al., 
1987; Law et al., 1986; Scott et al., 1987). The α -helices of apoB-100 contain hydrophobic and charged 
amino acid residues and are thus well adapted to bind lipid surfaces (Das and Gursky, 2015). 
Nascent apoB-100 protein is lipidated as it is translated into mature protein in the endoplasmic reticulum 
(Fisher and Ginsberg, 2002; Olofsson and Boren, 2012; Rustaeus et al., 1998), through several lipid binding 
sites in the protein structure (Scott et al., 1987; Zhou, Fisher, and Ginsberg, 1998). Lipids are included in a 
quality control of the forming lipoprotein particle: polyunsaturated fatty acids are easily peroxidized. As they 
are incorporated in the nascent lipoprotein, the particles contain lipid peroxides, which can lead to 
aggregation of the incorrectly lipidated apoB (Pan et al., 2008). Such particles are substrates to post-ER 
presecretory proteolysis, and are therefore not released into circulation but degraged intracellularly (Pan et 
al., 2004; Pan et al., 2008).  
Along with the apoBs, the lipoproteins can have exchangeable lipoproteins carried with them. Several copies 
of each exchangeable apolipoproteins can be found in the larger lipoprotein particles, chylomicrons, VLDL, 
and IDL. These particles carry apoE, apoC-III and II, apoA-I and II, and apoD, all of which they gain mainly 
from circulating HDL-particles (Havel, Kane, and Kashyap, 1973; Nakajima et al., 2011). In the LDL-
particles, there are only trace amounts of apolipoproteins other than apoB-100 (Bancells et al., 2010; De 
Castellarnau et al., 2000). LDL can also carry some acute phase proteins like serum amyloid A (Bancells et 
al., 2010). HDL has two pieces of scaffolding proteins, usually two to three copies of apoA-I (Huang et al., 
2011). Every fourth particle, however, has heterodimers of apoA-I and apoA-II. The HDL-particles can 
contain also other exchangeable apolipoproteins. ApoE is a largely α-helical protein (Chen, Li, and Wang, 
2011) synthesized mainly in the liver (Wu and Windmueller, 1979; Zannis et al., 1981). It has affinity to 
LDL-receptor and proteoglycans (Ji, Pitas, and Mahley, 1998). Also macrophages (Zhang, Gaynor, and 
Kruth, 1996), especially foam cells (Laffitte et al., 2001) express and secrete apoE, and to a smaller extent 
also adipocytes and cells of small intestine (Laffitte et al., 2001). It is transferred to apoB-containing 
lipoproteins in circulation from HDL-particles. ApoC-III is another component of VLDL, also a small 
exchangeable lipoprotein that also is found in HDL. Liver cells express it, and it consists of 79 amino acids 
and contains several amphipathic α-helices (Gangabadage et al., 2008). All exchangeable apolipoproteins 
have an amphipathic α -helical structure that can easily associate to lipid surfaces, and can also transiently 
dissociate from the lipoprotein particle surfaces (Das and Gursky, 2015). 
 
Chylomicrons, VLDL, IDL, LDL, HDL  
In the normal cholesterol metabolism there are two pathways (Brown, Kovanen, and Goldstein, 1981). The 
first is an exogenous pathway, which includes the cholesterol derived from dietary sources and then 
transported eventually to liver in the chylomicros and chylomicron remnants (Figure 6). The second pathway 
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is the endogenous pathway (Figure 6), where the liver produces TAGs out of carbohydrates and fatty acids 
and produces the apoB-100-containing lipoproteins in which the TAGs along with cholesterol, as CE, are 
transported to extrahepatic cells. This endogenous pathway can be devided into two branches: VLDL, 
intermediate density lipoproteins (IDL), and LDL transport cholesterol to the extrahepatic tissues, and in 
reverse cholesterol transport, when HDL transports cholesterol from the peripheral cells to the liver. (Figure 
6) Next, these lipoproteins will be discussed in more detail.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chylomicrons 
Lipoproteins carry hydrophobic lipids and lipid soluble substances, such as α-tocopherol, α- and β-carotene 
in the blood stream. The first in line are chylomicrons that form in the small intestine out of the dietary 
lipids. The ingested lipids have been disassembled into 2-monoacyl glycerol and fatty acids by pancreatic 
lipase, absorbed by intestinal cells, and in the cells, reassembled into trigacylglycerols (TAG). 
Chylomicrons, as other lipoproteins as well, consist of amphipathic, phospholipid-rich and unesterified 
cholesterol-rich surface and hydrophobic core. In the chylomicron core, there are TAG, cholesteryl esters 
Figure 6. Schematic picture of lipoprotein metabolism. 
20 
 
(CE), and also small amounts of unesterified cholesterol. In the capillaries, lipoprotein lipase (LPL) lipolyzes 
the TAGs from the chylomicron particles to be used for energy in the peripheral tissues (Redgrave and Zech, 
1987) or, to much greater extent, to be stored in the adipose tissue. Resulting chylomicron remnants, which 
have been stripped of most of their TAGs, are promptly taken to be processed in the liver, where remaining 
TAGs, cholesterol (esterified and unesterified), and phospholipids as well as the amino acids of the protein 
moiety are repurposed asVLDL (Grundy, 1978) (Figure 6).  
VLDL, IDL, and LDL 
VLDL-particles are loaded in the liver with TAGs and CEs. TAGs are the major lipid group (64 %) in 
VLDL, while proportion of chylesteryl esters is much lower (Table IB). The surface of VLDL-particle 
consists of phosphatidylcholines (PC) and sphingomyelins (SM), but some unesterified cholesterol is also 
buried in between the surface phospholipids. As VLDL releases most of its TAGs by the action of 
lipoprotein lipase, it gains density and becomes first IDL, and finally LDL (Table IA) (Figure 6).  
LDL lipidome is dominated by CEs (nearly 50 % of total lipids of LDL,Table IB), which it distributes into 
cells for construction of hormones, bile acids, steroid hormones, vitamin D, and as a structural lipid of cell 
membranes. In the core of LDL, there are also unesterified cholesterol, TAGs, and fatty acids. Unesterified 
cholesterol is found also on the surface of the LDL-particle, and the surface contains as much as two thirds 
of the total unesterified found in the particle (Hevonoja et al., 2000).The surface of the LDL-particle consists 
of mainly of phospholipids, of which the PC are the most abundant, and SMs are the second most abundant 
phospholipid group. Also minor quantities of phosphatidylethanolamine and phosphatidylinositol are found. 
One LDL-particle consists of 25 % protein and 75 % of lipid (Goldstein and Brown, 1977). 
The physical and chemical characterist of VLDL and LDL 
VLDL is 30 to 80 nm in size and its density has been determined to be 0.95-1.006 g/ml (Methods in 
enzymology, vol 263 (Chapman, 1986). Once the lipoprotein has reached the density 1.019-1.063 g/ml and 
the size 18-30 nm, it is called LDL. 
Ratio of cholesterol to total phospholipid (Chol/PL) can be used to describe the ratio of surface 
phospholipids to the core lipids in the circulating lipoproteins and it is often calculated when the degree of 
lipolysis of the lipoproteins is analyzed. Thus it is necessary to discuss the values of the normal circulating 
lipoproteins. In VLDL, the ratio of Chol/PL is 0.8 (Winocour et al., 1992) (Table IB). According to Chao 
and co-workers, in LDL the ratio Chol/PL is 2.5. (Chao et al., 1992), showing an increase in the proportion 
of cholesterol when compared to VLDL. Havel and co-workers measured the Chol/PL-ratio as they 
fractioned human plasma lipoproteins with ultracentrifugation (Havel, Eder, and Bragdon, 1955). In the 
density fraction d < 1.019, which contains VLDL and IDL, the ratio was 0.82, and in the density fration d = 
1.019–1.063 containing LDL, the ratio was 1.39 (Havel, Eder, and Bragdon, 1955). Another ratio, PC to SM 
(PC/SM) can be utilized when the lipoproteins are analyzed. Holcapek and co-workers measured 
phospholipid characteristics of plasma lipoproteins and according to their study, PC/SM-ratio was 3.6 in 
VLDL and 2.1 in LDL, measured with ultrahigh - performance liquid chromatograph - atmospheric pressure 
chemical ionization - mass spectrometry (Holcapek et al., 2015), and earlier Esterbauer and co-workers, and 
Sommer and co-workers have reported similar results (2.4, 2.4, and 2.3, respectively) (Esterbauer et al., 
1992; Sommer et al., 1992). 
HDL 
HDL is generatedeither by the action of lipoprotein lipase on VLDL which generates HDL particles when 
the excess phospholipid surface is dissociated from VLDL-particles, or as the nascent apoA-I collects lipids 
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from peripheral cells. Lipid-poor HDL is discoidal in shape and only gains spherical form after it takes up 
unesterified cholesterol and phospholipids from peripheral cells by a process mediated mainly by the 
transmembrane cholesterol transporter ATP-binding cassette A1 (ABCA1) (Alexander et al., 2011; Lee-
Rueckert, Escola-Gil, and Kovanen, 2016) (Figure 6). The unesterified cholesterol in the discoidal HDL is 
esterified by the lecithin-cholesterol acyltransferase (LCAT), and the formed CEs then gradually form a core, 
so leading to the generation of mature spherical HDL particles. The CEs of the mature HDL particles can 
then be transferred from the HDL particles, catalyzed by the CE transfer protein (CETP) in exchange for 
TAGs, to VLDL and IDL particles (Barter et al., 2003; Barter, Hopkins, and Calvert, 1982). Ultimately the 
CEs are taken up by hepatocytes either directly from the mature HDL particles via the scavenger receptor 
class B type I (SR-BI) receptor, or via the hepatic LDL receptors when the apoB-100-containing lipoproteins 
(mainly LDL particles, or VLDL and IDL to a smaller extent) are taken up by these receptors (Lee-Rueckert, 
Escola-Gil, and Kovanen, 2016).  
Nearly half of the lipidome of mature HDL isolated from serum consist of phospholipids, however, the 
composition may differ between different HDL subclasses (HDL2 and HDL3) (Wiesner et al., 2009). In 
nascent HDL most of the phospholipids are PC, and PC/SM ratio can be even 7 (Duong et al., 2006). In 
mature HDL the phospholipid contents vary between HDL classes (Kontush, Lhomme, and Chapman, 2013). 
Phospholipid content makes HDL is the major carrier of phospholipids in circulation (Wiesner et al., 2009), 
and up to 15 % of phospholipids can be LPC (Kontush, Lhomme, and Chapman, 2013). Most of the CEs in 
HDL is cholesteryl linoleate, and that is enriched especially in HDL3 (Kontush et al., 2007). 
Table IA. Lipoprotein characteristics. Apolipoproteins, protein- and lipid content, density, and 
particle size of plasma lipoproteins.  
 Structural protein 
Exchangeable 
apolipoproteins 
Proteins 
(% dry 
weight) 
Total 
Lipid (w 
%) 
Density 
(g/ml) 
particle 
size 
(nm) 
Chylomicron apoB-48 A-I,A-II, A-IV, C-I, C-II, C-III, E 1—2 99 <0.95 75—1200 
VLDL apoB-100 C-I, C-II, C-III, E 5—10 91 0.95—1.006 30—80 
IDL apoB-100 C-I, C-II, C-III, E 15—20 91-80 1.006—1.019 25—35 
LDL apoB-100 Trace amounts of E 18—25 75 1.019—1.063 18—30 
HDL apoA-I, A-II 
A-I, A-II, A-IV, C-I, 
C-II, C-III, E 40—55 44 
1.063—
1.210 5—12 
HDL2 
apoA-I, apoA-
II  
A-I (65%), A-II (10%), C 
(10-15%), E (3-5%) 35—40 59 1.063—1.125 8—11 
HDL3 
apoA-I, apoA-
II  
A-I (62%), A-II (23%), A-
IV (trace), C (5%), E (1%) 54—59 40—45 1.125—1.21 6—9 
(Hilbert T, 2007), (Chapman, 1986), (Pownall H.J., 1999), (Esterbauer et al., 1992)  
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Table 1B. Lipoprotein characteristics. Lipid compositions of plasma lipoproteins. 
 Total Phospholipids 
Phosphatidyl -
cholines 
Lyso 
PC 
Sphingo 
myelins 
Neutral 
lipids 
Triacyl–
glycerols 
Cholesteryl 
esters 
Unesterified 
cholesterol 
Chylomicrons 
(%)* 7     86 3 2 
VLDL (%)*, £ 18 14 0.8 2 84 55 12 7 
IDL (%)* 19 15  4 81 23 29 9 
LDL (%) $, *** 27.5 13.8 2.4 5.6 77 5.2 48.9 18.3 
LDL 
(moles/mole 
LDL)$ 
900 450 80 185 2370 170 1600 600 
HDL (%)**** 33 33-45 0.5-5 5-10 35-52 5-12 30-40 5-10 
* (Pownall H.J., 1999), **(Hussain, 2000), $ (Hevonoja et al., 2000), ***(Esterbauer et al., 1991), ****(Kontush, Lhomme, and 
Chapman, 2013; Wiesner et al., 2009), £ (Chapman, 1986)  
 
Main lipids in the lipoproteins 
Cholesterol and cholesteryl ester 
 
 
 
 
 
Cholesterol (Figure 7) (C27H45OH) has tetracyclic ring structure of sterols, which makes the structure very 
rigid. The hydroxyl (-OH) group in C3 is important for polarity and hydrogen bonding, and the aliphatic side 
chain in C17 increases hydrophobicity. It is a lipophilic, nearly water-insoluble (1.8 mg/l), waxy substance 
that crystallizes easily. Cholesterol crystallizes with triclinic basic structure, where crystals have no 90 
degree angles (Shieh, 1977).  
Cholesterol is transported and stored in esterified form, as CEs. CEs are formed when a fatty acyl chain is 
esterified with hydroxyl group in C3 (Figure 7). Esterified cholesterol is more hydrophobic than unesterified 
cholesterol, due to an aliphatic carbon chain of fatty acid. The length of the fatty acid determines the degree 
of hydrophobicity. Due to high hydrophobicity, CEs are transported in the core of lipoprotein particles.  
Cholesterol biosynthesis pathway is a highly conservative multi-step pathway, in which one enzyme, 
hydroxyl-methyl glutaryl-CoA reductase controls the rate limiting step. This step can be inhibited with 
statins, and thus the synthesis of cholesterol is prevented.  
  
Figure 7. Cholesterol and 
cholesteryl ester. adapted by 
(Liebisch et al., 2006) 
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Triacylglycerols 
 
 
 
 
 
TAGs (Figure 8) are storage lipids, stored mainly in adipocytes, and can be hydrolyzed and used as energy in 
muscle, especially in heart muscle. TAGs are comprised of a glycerol backbone and three fatty acid chains, 
where fatty acids form ester links with the hydroxyl groups of glycerol. As neutral lipids the TAGs are 
highly hydrophobic. TAGs are the major form of fat in human diets. The ingested TAGs are dismantled into 
mono- and diglycerides and fatty acids in the intestinal lumen by pancreatic lipase, then taken up to the cells 
cells lining the intestine and reassembled back to TAGs for transport. TAGs are transported initially in the 
chylomicrons to the liver, and in the liver they are packed into very low density lipoprotein (VLDL) to be 
transported to the peripheral tissues.  
Phospholipids 
 
 
 
 
 
 
 
 
Phospholipids are a heterogeneous group of amphipathic lipids, and they compose 23 % of the total lipids of 
low density lipoprotein (Esterbauer et al., 1992). The major groups of phospholipids are 
glycerophospholipids, which consists of the same glycerol backbone as TAGs, two fatty acyl side chains and 
an amphipathic head group attached to the glycerol backbone via phosphate group. The main 
glycerophospholipid groups are PC (Figure 9), phosphatidylethanolamine (PE), phosphatidylinositol (PI), 
and phosphatidylserine (PS). In natural phospholipids, unsaturated fatty acids are often in the sn-2 position of 
the glycerol backbone, while the sn-1 position is often occupied by a saturated acyl chain (Beermann et al., 
2005; Mitchell, Straume, and Litman, 1992). The degree of unsaturation affects the membrane rigidity 
(Mitchell, Straume, and Litman, 1992). Glycerophospholipid can be degraded to lysophospholipids. The 
glycerophospholipids lose an acyl group and as a result contain the amphipathic head group and one acyl 
chain attached to the glycerol back bone. PC can be hydrolyzed to lysophosphatidylcholine (LPC), where the 
acyl chain in sn-2-position is hydrolyzed as a result of enzymatic hydrolysis or oxidation. The responsible 
enzyme, PLA2 and the hydrolysis will be discussed later in the chapter Phospholipase A2, page 23 
Figure 9. Phosphatidylcholine and sphingomyelin. Letter R 
in sphingomyelin stands for an acyl group. 
Figure 8. Triacylglycerol. In figure is 
depicted a 1-linolenic-2-palmitic-3-
oleic triacylglycerol (TAG 52:4).  
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SMs (Figure 9) have a close resemblance of glycerophospholipids, but instead of sn-1 acyl chain they 
contain an aminoalcohol called sphingasine. The head group of glycerophospholipids can be either choline, 
serine, ethanolamine, inositol, or glycerol, and, similarly, in SMs a variety of head groups can be attached to 
phosphate group. 
Fatty acids 
 
 
 
 
 
 
Fatty acids are the building blocks of CEs, TAGs, and phospholipids. Fatty acids are aliphatic, unbranched 
hydrocarbon chains of 4—32 carbons, usually with an even number of carbons, a carboxyl group in the end. 
They can be saturated with no double bonds or unsaturated with varying amounts of double bonds (Figure 
10). The most relevant fatty acids in human physiology are palmitic acid (16 carbons, no double bonds 
(16:0)), palmitoleic acid (16 carbons, one double bond (16:1)), myristic acid (14:0), stearic acid (18:0), oleic 
acid (18:1), linoleic acid (18:2), a-linolenic acid (18:3), arachidonic acid (20:4), eicosapentaenoic acid 
(20:5), and docosahexaenoic acid (22:6). Fatty acids can also be found free in lipoproteins, for example low 
density lipoprotein (LDL) contains less than 1 % free fatty acids (Esterbauer et al., 1992). 
 
Aortic stenosis and atherosclerosis 
 
 
 
 
 
 
 
 
 
 
Figure 10. Fatty acids 
Figure 11. A Normal aortic valve leaflet. B. Aortic sclerosis. Lipids accumulate in the proteoglycan 
matrix and microscopic calcium crystals begin to form in the leaflet. C. Aortic stenosis. Lipid droplets 
have accumulated in the proteoglycan-containing matrix and calcification is extensive. The leaflets 
also contain inflammatory cells and lipid filled foam cells. 
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The onsets of aortic stenosis and atherosclerosis are gradual, and the changes in the tissues are stealthy. 
Atherosclerosis is an intimal disease, initiated by lipoproteins entering the arterial intima and retaining in the 
dense proteoglycan matrix (Williams and Tabas, 1995). In the course of the disease, the healthy thin intima 
thickens to contain retained lipoproteins and inflammatory cells such as macrophages, which will become 
foam cells after consuming the modified retained lipoproteins. Aortic valve is a distinctive part of vascular 
system, and aortic stenosis has many similarities to atherosclerosis (Otto, 2004), such as increasing of the 
proteoglycan matrix and lipid accumulation. In early stage of aortic stenosis (aortic sclerosis) the aortic 
leaflets are starting to fill with lipid and contain microscopic calcific nodules (Figure 11), (Freeman and 
Otto, 2005). Aortic stenosis is characterized not only by lipid accumulation, but also by extensive calcified 
nodules in the valve leaflets (O'Brien et al., 1996). 
 
 
 
 
 
 
 
 
 
 
 
Lipids accumulate in the arterial intima as plasma lipoproteins enter the intima and are retained in the 
proteoglycan matrix and macrophage-derived foam cells fill up with lipid droplets. Stary et al have defined 
the different stages of atherosclerosis from normal arterial intima to very advanced lesions (Figure 12), and 
describe the distribution of the lipids with photomicrographs and electron microscopy images on each stage 
(Stary, 1994; Stary et al., 1992; Stary et al., 1995; Stary et al., 1994b).  
Proteoglycans in the valve leaflets and in arterial intima 
In normal aortic valve leaflets, versican, decorin, hyaluronan, and biglycan are the dominant proteoglycans. 
Myofibroblasts in fibrosa secrete especially decorin, but the total proteoglycan content of fibrosa is lower 
than in the other layers (Stephens, Chu, and Grande-Allen, 2008). Proteoglycan distribution of the spongiosa 
differs from fibrosa and ventricularis as the spongiosa contains more versican and hyaluronan than the other 
two layers do (Stephens, Chu, and Grande-Allen, 2008). Biglycan is overexpressed in stenotic aortic valves 
(O'Brien 2004, Song 2012), and it is found in the fibrosa and ventricularis layers (Djerbali 2010).  
In electron microscopy images of arteries, collagen bundles are frequently found (Nievelstein et al., 1991; 
Simionescu et al., 1986), and collagen was found to co-localize with proteoglycans (Wight and Ross, 1975a). 
In arterial intima, smooth muscle cells secrete collagen, which in part stabilizes the forming neointima, but 
also binds proteoglycans, such as biglycan (Schönherr et al., 1995b) and decorin (Schönherr et al., 1995a), 
Figure 12. Schematic picture of normal 
intima (I), Stages II, III, IV, V, and VI. In 
stage II, macrophages have started to 
accumulate in the thickened intima, in 
Stage III early lipid accumulation can be 
found. In stage IV, lipid core has begun to 
form near the internal elastic lamina and 
the intima has thickened remarkabaly. 
Stage V is a fibrous lesion, containing 
thick layers of connective tissue and a 
thick fibrous cap. In stage VI, hematoma 
and thrombus are found. Modified from 
(Stary et al., 1995) 
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and in immunohistochemistry is found to co-localize with them in the normal and atherosclerotic 
arteries(Riessen et al., 1994). In ta study of arteries of non-human primates (Macaca nemestrina), normal 
arteries contained mainly perlecan, decorin, and biglycan in the vicinity of endothelial cells, and perlecan, 
decorin, biglycan, and versican where smooth muscle cells were found (Evanko et al., 1998). In fibrous 
plaques, they found that different combinations of proteoglycans were formed in different areas of the 
plaque: smooth muscle cell –rich areas contained perlecan, biglycan, versican, and hyaluronen, whereas 
areas rich in macrophages were rich in decorin, but poor in versican, and the fibrous cap was shown to be 
poor in perlecan and decorin, but rich in versican and biglycan (Evanko et al., 1998; Wight and Ross, 1975a; 
Wight and Ross, 1975b).  
Matrix remodeling of aortic valve leaflets and intimal thickening in arteries  
In aortic valves, the early lesion stage manifest as thickening (Otto et al., 1994). Cell density is increased 
especially in the fibrosa, while in the spongiosa layer, the amount of collagen is increased (Olsson 1994b). 
Aortic valve sclerosis is often considered as an early stage of aortic stenosis, as the changes that are at their 
strongest manifested in the aortic stenosis, can be found already in the aortic valve sclerosis. Such changes 
are accumulation of foam cells, fibroblasts expressing smooth muscle cell-like features, and early 
mineralization (Prasad and Bhalodkar, 2004). 
Diffuse intimal thickening in arteries is likely to occur at long non-branching segments of arteries, or 
paradoxically, at sites around branches (Nakashima et al., 2002; Stary et al., 1992). This intimal thickening 
starts as an adaptive phenomenon. A prerequisite of the pathological intimal thickenings are the benign, 
physiological adaptive intimal thickening sites, which will eventually become pathological. Pathological 
intimal thickenings contain retained and modified lipoproteins in the increased proteoglycan matrix, 
inflammatory cells, including macrophage and smooth muscle cell -derived foam cells, and in the advanced 
stage, a necrotic core that has been formed by dead foam cells (Nakashima et al., 2007). 
Nakashima studied arteries from fetuses to adults at their 30's (Nakashima et al., 2002). His group showed 
that diffuse intimal thickening was present in coronary arteries already in the prenatal stage, while in the 
distal arteries like in the splenic artery, only minimal adaptive intimal thickening could be detected in young 
Japanese adults, whose coronary arteries had already prominent adaptive intimal thickening (Nakashima et 
al., 2002). The exact point when an adaptive intimal thickening in the arteries turns pathological is hard to 
distinguish, as both adaptive and also the pathological intimal thickenings may coincide in atherosclerotic-
prone areas (Riessen et al., 1994; Stary et al., 1992).  
In areas where hemodynamic forces, wall tension, eddy currents and shear stress affect the artery 
(comprehensivlye reviewed by (Chiu and Chien, 2011) and cause an endothelial erosion where the 
endothelial cell layer is compromised and platelets attach to the surface (Mäyränpää et al., 2007). Endothelial 
dysfunction is associated with both aortic sclerosis and atherosclerosis (Anderson et al., 1995; Chenevard et 
al., 2006; Poggianti et al., 2003).  
Lipoproteins in aortic valve and arterial wall  
In work of Nievelstein et al (Nievelstein et al., 1991) a bolus of LDL particles was injected into a rabbit, and 
after just two hours, the lipid particles were found within the aortic proteoglycan matrix. Some of the 
particles seemed to be aggregated and even fused together to form larger particles. However, no such clusters 
or aggregates were present in the injected lipid prior to injection (Nievelstein et al., 1991). Nievelstein-Post 
and co-workers used also rabbit heart valves (aortic valve and atrio-ventricular valve) as a model tissue to 
examine how lipoproteins enter the intima and associate with the extracellular matrix (Nievelstein-Post et al., 
1994). In this experiment, LDL entered the valve within two hours of incubation, and the authors concluded 
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that the accumulation is due to interactions between the lipoproteins and the matrix in the intima. Stender 
and Hjelms (Stender and Hjelms, 1984) had performed a similar experiment on human subjects, injecting 
radiolabeled cholesterol-containing lipoproteins into patients undergoing an operation to replace aortic valve. 
In the in vivo human experiment of Stender and Hjelms, a very small amount of radiolabeled lipoproteins 
entered the aortic intima 12 to 40 minutes after the injection. 24 hours after the injection of radio-labeled 
lipoproteins, the radioactive label accumulated in the aortic intima much more than in the media.  
Frank and Fogelman show in an experiment where they feed rabbits with cholesterol-rich diet for 10 days, 
the aortic intima filled with lipid inclusions (Frank and Fogelman, 1989). They reported that no lipid is 
visible in the intima of the control rabbits, although, some granule-like structures were found attached in the 
fiber-like structures (Frank and Fogelman, 1989).  
Animal experiments with genetically hyperlipidemic or cholesterol-fed rabbits show how intact endothelium 
is nearly impermeable to particles that are larger than LDL (Nordestgaard, Wootton, and Lewis, 1995; 
Nordestgaard and Zilversmit, 1988; Stender and Zilversmit, 1981), although previously Nordestgaard and 
co-workers had stated that lipoproteins that are smaller than 75 nm can enter the intima through the 
endothelium (Nordestgaard and Zilversmit, 1988). Endothelial damage will enhance the entrance (Frank and 
Fogelman, 1989). Plasma macromolecules, including apoB-containing lipoproteins have been shown to enter 
the intima through healthy endothelium through transcytosis (Simionescu, Gafencu, and Antohe, 2002). 
Accumulating apoB-containing lipoproteins can then lead to endothelial dysfunction and subsequent increase 
of endothelial layer permeability, as products of their lipolysis will damage the endothelium, and allow the 
particles to penetrate into the intima (Eiselein et al., 2007). In porcine and murine arteries, (Kwon et al., 
1998) LDL was found to bind in the branching cites of the large arteries if the elastin basement membrane 
was compromised. Similar effect was found in porcine valves, where LDL bound to elastin-poor surface 
(Neufeld et al., 2014). 
Nakashima and co-workers (Nakashima et al., 2007) demonstrated that accumulation of lipoproteins in the 
intimal matrix is the initial phenomenon in lesion development. In the intima, the first deposits are diffuse 
and not visible in light microscopy (Nakashima et al., 2007; Nievelstein-Post et al., 1994; Nievelstein et al., 
1991). As internal elastic lamina, despite its fenestrations, inhibits spontaneous diffusion of lipoprotein 
particles and as arterial intima lacks lymphatic vasculature (Nakano et al., 2005), the lipoprotein particles are 
not drained from the intima, but rather accumulate there. Also aortic valve leaflets lack lymphatic vessels 
(Bradham et al., 1970), however no internal elastic lamina exists in the valve. In both atherosclerotic artery 
intima and in stenotic aortic valves lymphatic vasculature increases, still in both tissues, the imbalance 
between influx of lipoprotein particles and drainage through the lymphatic vasculature remains (Nakano et 
al., 2005; Syväranta et al., 2012). Due to the imbalance, lipoprotein particles accumulate in both arterial 
intima and aortic valve. 
ApoB, apoE, and apoA-I are found to be able to interact and co-localize with biglycan in the atherosclerotic 
lesions (O'Brien et al., 1998), and all these apolipoproteins also co-localize with biglycan in stenotic aortic 
valve lesions (Lommi et al., 2011; O'Brien et al., 1996). Biglycan is shown to bind apolipoproteins B-100 
and E (O'Brien et al., 1998; Olin et al., 2001) and apo A-I has been shown to perfectly co-localize with 
biglycan by immunohistochemical stainings, most likely as part of the apoE-containing VLDL, VLDL-
remnants or HDL-particles (O'Brien et al., 1998; Olin et al., 2001). In immunohistochemistry, versican, the 
most abundant intimal proteoglycan (Camejo et al., 1998; Theocharis et al., 2001), has been found not to co-
localize with apoB-100 or apoE both in human coronary arteries (O'Brien et al., 1998) or in mice aortas 
(Kunjathoor et al., 2002), although LDL has been shown to have high affinity on versican-like proteoglycans 
(Camejo et al., 1993). This may also be due to loss of apoB-100 immunoreactivity in atherosclerotic lesions 
(Kruth and Shekhonin, 1994).  
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Once the apoB-containing lipoproteins have entered the subendothelial space, they are retained in the 
proteoglycan matrix (Simionescu et al., 1986; Skålen et al., 2002). ApoB-100 has in vitro affinity towards 
proteoglycans via its basic amino acids, in particular near the LDL-receptor binding site (residues 3359-
3369) (Skålen et al., 2002). ApoE-containing lipoproteins are able to attach the proteoglycans also via apoE's 
ionic affinity to biglycan, although the affinity of apoB to this proteoglycan is higher than that of apoE (Olin 
et al., 2001). In concordance with the Response-to-retention hypothesis, the retained lipoprotein particles in 
the proteoglycan matrix are susceptible to modifications by oxidation, proteolysis, and lipolysis (Williams 
and Tabas, 1995). 
After the injection of LDL into the rabbit circulation, Nievelstein and co-workers observed aggregates of 
LDL-sized lipoproteins and also enlarged particles that they suggested to be fused lipoproteins (Nievelstein 
et al., 1991). Also Frank and Fogelman observed large clusters of lipid particles in the extracellular matrix of 
cholesterol-fed rabbits (Frank and Fogelman, 1989). Pentikäinen and co-workers showed in in vitro 
experiments that such aggregates can be results of agitation, immune-complexes, oxidation, proteolysis or 
lipolysis (Pentikäinen, Lehtonen, and Kovanen, 1996). Lipolysis, oxidation, and proteolysis will be discussed 
in more detail below, on pages 24, 26, and 27, respectively. In vivo, especially deeper in the intima, also 
acidic extracellular pH can contribute to aggregation of lipoproteins (Öörni et al., 2015). Intimal 
macrophages (Tabas, Williams, and Boren, 2007) and smooth muscle cells (Allahverdian, Pannu, and 
Francis, 2012) take up the aggregated lipoproteins and become foam cells. Foam cells will be discussed in a 
later chapter (Page 29). 
Modifications of apoB-100-containing lipoproteins in atherosclerosis 
Lipolysis and lipolytic enzymes 
Lipoproteins from chylomicrons to LDL are targets of lipolysis. Via lipolysis, the TAGs in the TAG-rich 
lipoproteins are hydrolyzed to glycerol and fatty acids to be used for energy in the muscles and, on the other 
end, the excess fatty acids that were not necessary for energy will be stored in adipose cells or used as raw 
material for biosynthesis. CEs are hydrolyzed into cholesterol and fatty acids, and the unesterified 
cholesterol is used in peripheral steroidogenic cells to produce glucocorticoid hormones or steroid hormones. 
Phospholipids are hydrolyzed for production of signal transduction molecules, such as ceramides, fatty acids, 
eicosanoids, or inositol phosphates. These physiological lipolysis pathways are also found to affect 
pathological events in atherosclerosis. Next, the lipolytic enzymes will be examined, as they can be factors in 
atherogenesis by lipolyzing lipoproteins and have also effects on the smooth muscle cells or macrophages. 
Sphingomyelinase  
Ceramides are detected in atherosclerotic plaques and they have been linked to progression of atherosclerosis 
(Edsfeldt et al., 2016). Fitting to that, acid sphingomyelinase (SMase) is detected in the intima (Edsfeldt et 
al., 2016). It promotes lipoprotein retention within early atheromata and accelerates lesion progression 
(Devlin et al., 2008). Acid SMase (SM phosphodiesterase (EC 3.1.4.12) (Barnholz, Roitman, and Gatt, 
1966), SMase) is secreted by both endothelial cells and intimal macrophages and it binds to matrix 
proteoglycan components and several types of collagen (Marathe et al., 1999; Marathe et al., 1998), and it 
has been found to have also mitogenic effect on smooth muscle cells in vitro (Auge et al., 1996). Secretion of 
SMase from the endothelial cells is stimulated by cytokines interleukin-1β (IL-1β), and interferons γ and β, 
as Marathe and co-workers showed in an in vitro experiment (Marathe et al., 1998). SMase hydrolyzes SM 
by removing the phosphocholine headgroup to produce ceramide that consists of sphingosine and a fatty 
acid. It is one of the enzymes that enhances lipoprotein aggregation and their affinity to human aortic 
proteoglycans (Öörni et al., 2005). Hydrolysis of LDL lipids by SMase distorts the protein conformation of 
apoB-100 bringing out hydrophobic parts of the protein (Sneck et al., 2012). This will induce aggregation of 
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the LDL-particles. Exhangeable apolipoprotein apoC-III in LDL increases the susceptibility of LDL to 
SMase (Schissel et al., 1998), by bridging SMase and membrane SM (Schissel et al., 1998) and this is 
notable particularly in LDL particles isolated from patients having type 2 diabetes (Hiukka et al., 2009). 
Hiukka and co-workers also show that LDL from patients with type 2 diabetes contain less ganglioside 1 
(GM1) than non-diabetic LDL, and that low GM1-levels were associated with high apoC-III levels. Fanani 
and co-workers had previously shown that GM1 inhibits SMase (Fanani and Maggio, 1997), so Hiukka and 
co-workers postulated that low GM1 levels can lead to increased hydrolysis by SMase (Hiukka et al., 2009). 
The SMase-hydrolyzed LDL has also greater affinity to proteoglycans (Hiukka et al., 2009) and collagen 
(Marathe et al., 1999). 
Phospholipase A2  
PLA2-family enzymes catalyze the hydrolysis of a fatty acid that is esterified in the sn-2 carbon of the 
glycerol back bone in glycerophospholipids. Hydrolysis produces a free fatty acid and a lysophospholipid. 
Murakami (Murakami et al., 2015; Murakami and Taketomi, 2015) has very recently reviewed the secretory 
PLA2-enzymes with great detail. There are ten major secretory PLA2-species and each have favorite 
substrate specificity. The PLA2s suggested to be significant in the development of atherosclerosis are PLA2-
IIa (Menschikowski, Hagelgans, and Siegert, 2006), PLA2-III (Sato et al., 2008), PLA2-V (Boström et al., 
2007), and PLA2-X (Bezzine et al., 2000) in the intima, and Lp-PLA2 which travels with LDL particles 
(Kolodgie et al., 2006) and has activity towards oxidized LDL in vitro. Of these, PLA2-IIa requires modified 
LDL as a substrate, but the activity towards native LDL is very modest (Hakala et al., 2001; Sartipy et al., 
1999), whereas PLA2-III, PLA2-V and PLA2-X are able to hydrolyze also native LDL phospholipids 
(Pruzanski et al., 2005; Rosengren et al., 2006; Sato et al., 2008). Apart from atherosclerosis, PLA2-IIA -
enzymes contribute to defence against pathogens, such as bacteria in the lung tissue (Movert et al., 2011). 
Group X PLA2 is expressed in the gastrointestinal tract and takes part in the lipid digestion (Murakami et al., 
2015) and PLA2-III contributes to mast cell maturation (Murakami and Taketomi, 2015). Arachidonic acid, 
as source of eicosanoids, is one of the fatty acids released from the phospholipid. Expression of PLA2-IIA or 
PLA2-X in mammalian cells is integral in a release of arachidonic adic from cells, and they work in co-
operation with cytosolic PLA2-enzymes (Mounier et al., 2004). The release of arachidonic acid is enhanced 
by IL-1β (Mounier et al., 2004).  
Hydrolysis of lipoproteins with PLA2 has also been shown to affect their affinity to the proteoglycans. 
Lipolysis of LDL with PLA2 increases remarkably the lipoprotein's affinity to proteoglycans and the same 
can be seen also in case of IDL- and VLDL-particles (Lähdesmäki et al., 2012). In native LDL, only one of 
the proteoglycan binding sites in apoB (site B, amino acid residues 3359-3369) is available (Boren et al., 
1998b), but after lipolysis with PLA2, also a second proteoglycan binding site (residues 3148-3158) is 
exposed and can bind to the proteoglycans, strengthening the binding (Flood et al., 2004). Unlike SMase, 
which is able to induce both fusion and aggregation of LDL-particles, PLA2-lipolyzed LDL-particles were 
only aggregated (Öörni et al., 1998). Interestingly, in the presence of glycosaminoglycans like heparin, also 
PLA2-treated LDL can form fused particles (Hakala et al., 1999). 
Apart from the phospholipids, also neutral lipids get lipolyzed in the LDL particles, a phenomenon that, as 
described below, induces aggregation of the lipoprotein, enhances retention to the proteoglycans, and 
facilitates uptake by macrophages. 
Lysosomal acid lipase 
Lysosomal acid lipase (LAL) (belongs to a family of acid lipases EC 3.1.1.13)(Ameis et al., 1994; Hyun et 
al., 1969; Lohse, Chahrokh-Zadeh, and Seidel, 1997), also known as CE hydrolase, is a necessary enzyme in 
the metabolism of CE-enriched lipoproteins, as it hydrolyzes their CEs in lysosomes into unesterified 
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cholesterol and free fatty acids (Ameis et al., 1994; Goldstein et al., 1975). In addition to cholesteryl esterase 
activity, LAL also has triacylglyceridase activity on TAGs having medium length (or long) acyl chains 
(Ameis et al., 1994; Lohse, Chahrokh-Zadeh, and Seidel, 1997). In in vitro -experiments, LAL shows higher 
activity as TAG-hydrolase than as cholesteryl esterase (Ameis et al., 1994), but it is the only lysosomal 
lipase that hydrolyzes CEs within lysosomes (Dubland and Francis, 2015). Recently LAL has been found to 
regulate VLDL synthesis in mice (Radovic et al., 2016). In macrophages it is found in the lysosomal 
compartment and it catalyzes the deacylation of TAG and CE of lipoproteins that have been taken up by 
macrophages (Goldstein et al., 1975; Sando and Rosenbaum, 1985). The resulting unesterified cholesterol is 
then re-esterified into CE in the macrophage lipid droplets (Brown, Ho, and Goldstein, 1980; Goldstein et al., 
1975), and the excess fatty acids are incorporated into phospholipids (Darmani, Harwood, and Jackson, 
1993). (This process of macrophage CE uptake is described in detail in the chapter Foam cells, page 29). In 
addition to its role in lysosomes, LAL is also secreted into pericellular space upon macrophage activation 
(Hakala et al., 2003; Schissel et al., 1998), and as it shares sequences and active site structures with human 
gastric lipase, it is plausible that it is able to function outside of the lysosomes in the pericellular space, given 
that the necessary acid pH is achieved (Lohse, Chahrokh-Zadeh, and Seidel, 1997; Sheriff, Du, and 
Grabowski, 1995; Öörni et al., 2015). Haka and her group showed how macrophages can create an acidic 
environment in the extracellular space around them by secreting the lysosomal contents in the so called 
surface connected compartments, i.e. invaginations at the cell surface (Haka et al., 2009), and thus the CE 
hydrolysis can take place outside the macrophages. They also show that LDL-aggregates form these acidic 
compartments in a murine J774-macrophage model (Singh et al., 2016). Both Chao and co-workers (Chao et 
al., 1992) and Bhakdi and co-workers (Bhakdi et al., 1995) suggest, that for LAL to work, and to be able to 
properly reach the lipoprotein core CEs and hydrolyze them, LDL needs a preceeding modif oxidation or 
proteolysis. Only modest aggregation can be detected on cholesteryl esterase treated LDL (Öörni et al., 
2000), while it forms then unesterified cholesterol -filled multilamellar bodies. Similar vesicles can be found 
also in aortic intima (Chao et al., 1992).  
Lipoprotein lipase  
Lipoprotein lipase (LPL) (EC 3.1.1.34) activity was first described by Hahn (Hahn, 1943) by its ability to 
clear lipids from the blood of dogs, however he did not yet recognize the enzyme itself, and Korn et al (Korn, 
1955a) isolated this “clearing factor” from rat hearts. LPL can lipolyze TAGs into three free fatty acids and 
glycerol, using mainly tri-, di-, and monoacylglycerols as substrates (Korn, 1955b; Miller and Smith, 1973). 
It can also hydrolyze PC (Scow and Egelrud, 1976) and PE (Groot, Oerlemans, and Scheek, 1978) as 
substrates, but those are minor substrates compared to TAGs. The enzyme’s primary function is to hydrolyze 
the TAGs from circulating triacylglyerol-rich lipoproteins chylomicrons, VLDL, and IDL by binding as a 
dimer to endothelial cell proteoglycans in capillaries, and concomitantly to the lipoproteins, whose TAGs it 
lipolyzes. A necessary activator of LPL is apoC-II that chylomicrons and VLDL carry (Chung and Scanu, 
1977). The resulting free fatty acids are to be used as energy by muscle cells or stored as TAGs in adipose 
tissue. Lipoprotein lipase is expressed also by tissue macrophages and it enhances VLDL, IDL, and LDL 
retention to proteoglycans mediated by LPL's binding to the phospholipid layer of the lipoprotein particles 
and thus bridging the two together (MacPhee et al., 1997; Pentikäinen et al., 2002). LPL is found to 
positively correlate with atherosclerosis in mice (Babaev et al., 1999; Van Eck et al., 2000), and in human 
macrophages LPL-gene is associated with foam cell formation as it increases VLDL and LDL uptake by 
macrophages (Olivier et al., 2012). Apolipoproteins apoC-I, C-II, and C-III, apoA-V, and apoE have been 
found to control LPL activity: apoA-V and apoC-II stimulates the TAG hydrolysis and apoC-I, apoC-III, and 
apoE inhibit it thus increasing circulating levels of TAG (Kersten, 2014). Also a group of angiopoietin-like 
(ANGPTL) protein family members can modulate the activity of LPL. ANGPTLs 3, 4 and 8, of which 
ANGPTL4 is a competitive inhibitor of LPL, reduce LPL activity and thus increase plasma TAG 
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concentration (Kersten, 2014). The role of ANGPTL 8 in mice has been found to increase plasma TAG by 
inhibiting LPL activity, and its actions have veen found to be tissue specific (Kersten, 2014), and the 
ANGPTL3 is supposed to work similarly as ANGPTL8. In a recent review by Tikka and Jauhiainen (Tikka 
and Jauhiainen, 2016) the role of ANGPTL3 role in lipoprotein metabolism is discussed in detail. 
Homozygous carriers of a rare loss of function mutation in the gene coding ANGPTL3 have a rare disorder 
familial combined hypobetalipoproteinemia, causing very low VLDL. LDL, and HDL levels (Tikka and 
Jauhiainen, 2016). Such loss of function mutations have been detected in some Italian, Spanish, and 
American families. The mutation carriers have been found not to suffer from serious adverse effects (Tikka 
and Jauhiainen, 2016). 
Oxidation of lipoproteins 
LDL oxidation enhances LDL aggregation in vitro, as shown by Pentikäinen and co-workers (Pentikäinen, 
Lehtonen, and Kovanen, 1996), and oxidized epitopes are found in arterial intimas (Ollikainen et al., 2016). 
The cholesterol moiety, the surface phospholipids, and the apoB-100 protein can all become modified via 
contact to transition metals, such as cupric ions (Cu2+), as Nichols found already 1961 by dialyzing LDL 
against cupric ion solution (Nichols, 1961). ApoB-100 of LDL is susceptible to non-enzymatic proteolysis 
where it is degraded independent of proteolytic enzymes by endothelial cell-derived oxygen free radicals 
(Fong et al., 1987). Each lipid class produces distinct oxidation products: 4-hydroxynonenal (4-HNE) and 
malondialdehyde (MDA) are derived from ω6 fatty acids by chain cleavage, and these can also modify 
proteins by covalently modifying the lysine residues of proteins, notably of the apoB-100 of LDL, and so 
generate 4-HNE-modified and MDA-modified LDL (Esterbauer et al., 1991; Fruebis, Parthasarathy, and 
Steinberg, 1992) The positively charged, "active" lysine residues that contribute to LDL binding to the 
proteoglycans are exposed on the surface of LDL particle and have lower pK compared to the other lysines 
of apoB-100 (Lund-Katz et al., 1988). The formation of 4-HNE-lysine and MDA-lysine adducts decreases 
the number of active lysine residues in apoB-100 of LDL and thus reduces the ability of LDL to attach to 
proteoglycans (Öörni et al., 1997). Oxidation releases fatty acids from phospholipids and, as a result, creates 
lysophospholipids (Steinbrecher 1984). Oxidation of cholesterol or CEs creates oxysterols such as 7-
ketocholesterol, 5,6-epoxycholesterol, and 7-hydroxycholesterol, the most abundant oxysterols in human 
LDL being 27-hydroxycholesterol and 7-ketocholesterol (Hulten et al., 1996; Zhang, Basra, and 
Steinbrecher, 1990). 7-ketocholesterol activates CE formation, and thus foam cell formation while 7-
hydroxycholesterol cholesterol inhibits cholesterol esterification and foam cell formation (Zhang, Basra, and 
Steinbrecher, 1990). Oxysterols have been found to contribute to inflammatory responses in tissues. 
Oxysterol 24-hydroxycholesterol, which mouse bone marrow macrophages secrete in response to Toll-like 
receptor activation (Diczfalusy et al., 2009), can affect inflammatory signaling in mice by inducing secretion 
of IL-6 (Gold et al., 2014). Also 4-HNE and 27-hydroxycholesterol are shown to induce expression and 
secretion of inflammatory cytokines TNF-a, IL-1β, and IL-8 in experiments with human promonocytic cell 
line U937, and the cells also produced matrix metalloproteinases upon activation by oxysterols (Gargiulo et 
al., 2015). Oxidized sterols can also reduce the activity of 3-hydroxy-3-methylglutaryl coenzymeA reductase 
(HMG-CoA reductase), the rate-limiting enzyme in cholesterol synthesis, thus reducing cellular cholesterol 
synthesis (Brown 1975), and they are also able to decrease the expression of lipoprotein lipase in human 
monocyte-derived macrophages as LPL mRNA is downregulated by oxysterols (Hulten et al., 1996). 
In vitro, LDL can be oxidized by a selection of oxidative agents available. Transition metal ions, like Cu2+ 
(Ray 1954) are potent oxidative agents in vitro, but they lack clinical significance. Other oxidative agents 
that can oxidize LDL in vitro, such as peroxides secreted by endothelial cells (Steinbrecher et al., 1984), 
cigarette smoke ingredients (Yokode et al., 1988), myeloperoxidase in combination with H2O2 (Podrez et al., 
1999; Savenkova, Mueller, and Heinecke, 1994), and the heme liberated from red blood cells (Miller, 
Altamentova, and Shaklai, 1997) are also relevant in atherosclerosis in vivo (Stocker and Keaney, 2004). 
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Plasma LDL transports several lipid-soluble antioxidant molecules that prevent oxidation of LDL in the 
circulation, such as α- and γ-tocopherol (vitamin E), lycopene, β-carotene, of which α-tocopherol is the most 
abundant (Esterbauer et al., 1991). These are consumed in the presence of oxidative agents, such as cigarette 
smoke, and eventually the lipids in LDL become oxidized (Valkonen and Kuusi, 1998).  
Proteolysis of lipoproteins 
The lipoproteins may become proteolyzed after they have entered the arterial wall or the aortic valve. Several 
different proteases are able to hydrolyze the protein moieties of lipoproteins. The neutral proteases plasmin, 
thrombin, and kallikrein are mainly derived from plasma (Piha, Lindstedt, and Kovanen, 1995), while 
cathepsin G is secreted by tissue resident macrophages (Wang et al., 2014), by neutrophils (Owen and 
Campbell, 1998) and by mast cells (Mäyränpää et al., 2006). Neutral mast cell proteases chymase and 
tryptase are also found in the arterial wall (Kovanen, Kaartinen, and Paavonen, 1995). In addition to the 
neutral proteases, acidic proteases, that are able to hydrolyze apoB-100 and other apolipoproteins, are found 
in the arterial wall. Cathepsins D (Hakala et al., 2003), F (Öörni et al., 2004), H (Han et al., 2003), K, and S 
(Sukhova et al., 1998) have been described to be present in atherosclerotic arterial wall. In stenotic aortic 
valves, mast cells (Wypasek et al., 2013), and hence the mast cell neutral proteases chymase, tryptase and 
cathepsins G are expressed in the diseased valves (Helske et al., 2006a). Moreover, the elastolytic cathepsins 
S, K, and V have been found also to be present in stenotic aortic valves (Helske et al., 2006b).  
 
Hydrolysis of apoB-100 of LDL particles by different proteases can induce their fusion. Piha et al (Piha, 
Lindstedt, and Kovanen, 1995) found that if the generated apoB-100 fragments are not released from the 
proteolyzed LDL particles, but remain particle-bound, as occurs after treatment of LDL with the plasmin, 
kallikrein, or thrombin, the particles do not fuse, while hydrolysis of apoB-100 by α-chymotrypsin (Piha, 
Lindstedt, and Kovanen, 1995) or mast cell proteases (Kovanen and Kokkonen, 1991) resulted in release of 
the formed peptides, and fusion of the proteolyzed LDL-particles. By hydrolyzing LDL and VLDL with 
cathepsin D, Chen et al found that apoB-100 in these lipoproteins have different amino acid sequences 
available for proteolysis (Chen et al., 1991). Hydrolysis in vitro with α-chymotrypsin slightly increases the 
size of the particles and their affinity of LDL-particles to proteoglycans (Öörni et al., 2005). The specificity 
of α-chymotrypsin is very similar to that of chymase, an important mast cell protease which is capable of 
hydrolyzing apoB-100 (Kovanen and Kokkonen, 1991). Cathepsins D (Chen et al., 1991), F, B, and to a 
lesser extent, S, and K have been to observed to increase the size of the LDL particles, as well as their 
aggregation, fusion, and their affinity to proteoglycans (Öörni et al., 2004). In the arterial intima, 
macrophages and smooth muscle cells secrete these proteases.  
Combinations of modifications 
Single modifications of LDL have been described to enhance LDL uptake by macrophages in vitro 
(Pentikäinen et al., 2000). In vivo, usually several lipolytic or proteolytic enzymes, as well as oxidating 
agents, may be available, and the lipoproteins present may get multiply modified. Schissel (Schissel et al., 
1996) isolated lipid particles from aortic intima and showed with in vitro -experiments that the particles were 
susceptible to hydrolysis by SMase, and that LDL hydrolyzes and aggregates more potently if LDL-particles 
were first oxidized or hydrolyzed with another lipolytic enzyme, PLA2 (Schissel 1998). Chao (Chao et al., 
1992) observed that trypsin pretreatment of native LDL, but not of oxidized LDL, was required for the CEs 
in the particle core to be hydrolyzed with cholesterol esterase. The reason for the oxidative modification to 
allow cholesterol esterase to act without prior proteolysis likely derives from the fact that also oxidation 
degrades apoB-100 and actually renders the surface of LDL particles unstable. E-LDL, an enzymatically 
multiply modified form of LDL, was immunohistochemically shown to be present in the arterial wall 
(Torzewski et al., 2004). E-LDL has been generated in vitro by treating LDL with trypsin and CEase to 
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mimic the lipid particles found in the intima. Trypsin was used in the model instead of matrix 
metalloproteinases (MMP) 2 and 9, that can degrade apoB-100 and make the LDL-particles more susceptible 
to macrophage uptake (Torzewski et al., 2004). E-LDL was found to induce foam cell formation in a mouse 
model (Chellan et al., 2016). Similarly, proteolysis combined with CE hydrolysis with LAL leads to 
enhanced aggregation of LDL and hence also enhanced uptake by macrophages (Hakala 2003). Plihtari and 
co-workers hydrolyzed LDL with several different proteases, chymase, plasmin, and cathepsin S that are 
found in the intima, and α-chymotrypsin, in combination with SMase and PLA2-enzymes, and showed that 
proteolysis enhanced phospholipolysis of the particles, but induced fusion of the particles only when the 
peptide fragments were released from the lipoprotein particles (Plihtari et al., 2010). Thus, proteolysis with 
cathepsin S and chymase enhances lipolysis by PLA2-V and SMase, and proteolysis before lipolysis can 
enhance the lipoprotein retention to proteoglycans (Plihtari et al., 2010). While not modifying LDL in the 
strict meaning of the word, amino acid exposure in apoB-100 is changed as LDL binds to the 
glycosaminoglycans. The binding to the glycosaminoglycans increases the exposure of segments that contain 
arginines and lysines on the surface of LDL, and also changes the organization of the core and the surface of 
the lipoprotein particles (Hakala et al., 1999). After LDL has been in contact with glycosaminoglycans, such 
as heparin, it is more potently hydrolyzed with PLA2, and is susceptible to fusion and aggregation(Hakala et 
al., 1999). Finally, subsequent in vitro -experiments of treating LDL with cholesteryl esterase following with 
SMase (Guarino, Tulenko, and Wrenn, 2004) have shown that cholesterol crystals can be generated when 
LDL-particles are multiply modified. 
Fate of modified lipoproteins 
Extracellular lipid particles 
In 1967 Smith and her co-workers (Smith, Evans, and Downham, 1967) showed that fatty streaks contained 
more lipid than normal intima and even more than advanced and fibrotic plaques. Lipid content of the intima 
reflects the source of the lipids: the CEs from "intima containing mainly perifibrous lipid" are rich in linoleic 
acid and the CEs from intima that contain foam cells are rich in oleic acid (Smith, Evans, and Downham, 
1967). Lesions, called as "fibrous plaques" by Smith et al, rich in perifibrous lipid were found to contain 
unesterified cholesterol, and the early lesions with perifibrous lipid contain as much as 25 % of free 
cholesterol (Smith, Slater, and Chu, 1968). The proportion of unesterified cholesterol increases in the lesion 
as the proportion of linoleic acid decreases, and they suggest that the increase of free cholesterol is due to 
extracellular CE hydrolysis. Another type of lesion, described by Smith and co-workers (Smith, Slater, and 
Chu, 1968) as "larger plaques with amorphous centres", contain as much as 44 % of free cholesterol in their 
amorphous centers while the proportion of oleic acid decreases. Chung and co-workers (Chung et al., 1994) 
characterized also the protein composition of aortic lipoprotein-like particles from human arteries. They 
showed with SDS-PAGE that the lipid particle material from human aortic plaques contain apolipoproteins 
B, E, A-I, and C's, similarly to plasma VLDL, but that in the advanced human plaques immunoreactive apoB 
had disappeared. Chung and co-workers suggest in their paper that the lipid particles would be derived from 
TG-rich lipoproteins and would be surface remnants generated by lipolysis due to the apoA-I and apoC-
content of the particles. 
By homogenizing human aortas having normal intimas or atherosclerotic plaques, derived from autopsy 
samples, Hoff et al isolated lipoprotein particles that were similar to plasma LDL (Hoff et al., 1979), and 
showed that the isolated particles contained apoB-100. Following that, Hoff and Gaubatz (Hoff and Gaubatz, 
1982) determined the chemical composition of aortic extracellular lipid particles and found that isolated 
lipids have similar or lower density than plasma LDL. Unesterified cholesterol content is increased in the 
particles isolated from a plaque, when compared to normal intima and plasma (Hoff and Gaubatz, 1982; 
Hoff, Pepin, and Morton, 1991). Hoff's work also shows that the fatty acid composition of the isolated lipid 
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particles is different in different stages of atherosclerosis (Hoff and Gaubatz, 1982). Guyton and Klemp 
(Guyton and Klemp, 1994)analyzed several human aortae fatty straks and plaque core and cap regions for 
free cholesterol and CEs. Their analysis showed that the oleate-enriched composition of the isolated lipid 
particles can be a marker of heavy deposit of lipid laden foam cells, in which the lipid particles contain 
mostly cholesteryl oleate, and that when the isolated lipids are linoleate-enriched, it can be a marker of 
mostly LDL-derived extracellular lipid, since LDL particles are enriched with cholesteryl linoleate (Guyton 
and Klemp, 1994; Smith, 1974). They calculated specific ratio (cholesteryl oleate/cholesteryl 
oleate+cholesteryl linoleate,) that describes the proportion of oleate-rich or linoleate-rich CE content and 
thus the origin of the extracted CEs. For comparison they calculated the same ratio from lipids that were 
extracted from LDL (0.32). In the fatty streaks, areas heavy with foam cells, the CE ratio was 0.8, showing 
heavy deposit of intracellular lipid on the area. In thevlipid deposits of the fibrous plaque and fibrolipid core 
the ratio was, in average 0.27—0.47, and from these results Guyton and Klemp suggest that both in the early 
and mature core regions, the main proportion of the lipid is derived from plasma lipoproteins as the CEs had 
a low oleate/linoleate ratio (Guyton and Klemp, 1994). In contrast to the core regions, however, their results 
showed that cap regions of these advanced plaques had high oleate/linoleate ratio, suggesting that these areas 
were rich in foam cells and intracellular lipid droplets derived from them (Guyton and Klemp, 1994).  
Kruth and co-workers (Kruth, 1984) described the distribution of extracellular CEs and unesterified 
cholesterol with Oil Red O and filipin-stainigns performed on human aortic tissue. Unesterified cholesterol is 
found in the extracellular compartment and esterified cholesterol, stained with Oil Red O, is found in the 
cells, and occasionally also in the extracellular compartment. Also cholesterol crystals were seen in the 
extracellular space. Shortly after Kruth and co-workers, Simionescu and her co-workers (Simionescu et al., 
1986) showed with electron micrographs that radiolabeled β-VLDL accumulated in aortic extracellular 
matrix of a cholesterol-fed rabbits (Simionescu et al., 1986). They named these structures "extracellular 
liposomes" and demonstrated liposome-like and multilamellar structures, rich in unesterified cholesterol. 
Similar structures are seen in rabbit aortic valves after a high fat diet (Simionescu et al., 1986).  
Pasquinelli and co-workers (Pasquinelli et al., 1989), examined several human carotid artery intimas and 
demonstrated multilamellar vesicles among smaller lipid particles in all stages of atherosclerosis. In their 
study, extracellular lipid particles found in the intima were larger than native LDL but smaller than 
intracellular lipid particles. Uni- and multilamellar lipid-containing vesicle-like particles were found also in 
the human and rabbit aortas by Chao and co-workers (1988) and by Guyton and Klemp (1989). Also the 
particles later isolated by Chao from where (Chao et al., 1990) showed multilamellar vesicle appearance. 
Chao and co-workers isolated extracellular lipids from human abdominal aorta samples and by aid of 
centrifugation divided them into unesterified cholesterol-rich and esterified cholesterol-rich categories (Chao 
et al., 1990). Results of Chao and co-workers showed that the particles are smaller (< 100 nm) than the 
intracellular lipid droplets (300 – 6000 nm). Also their lipid analysis results showed that the lipid particles 
from extracellular compartment of an aorta have different lipid characteristics compared with LDL-particles 
and their lipid content, as shown in Table II below.  
Table II Lipid characteristics of extracellular lipid particles of human abdominal aorta 
TC = Total cholesterol, PL = phospholipid, UC = unesterified cholesterol, SM = sphingomyelin, PC = 
phosphatidylcholine.  
 TC/PL UC/TC UC/PL SM/PC 
LDL 3.1 0.38 0.67 0.4 
CE-rich 10.1 0.24 2.5 1.7 
UC-rich 3.2 0.77 2.6 1.9 
(Chao et al., 1990; Esterbauer et al., 1992) 
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Accumulation of lipids in the arterial intima starts at very early age (Ylä-Herttuala et al., 1986). Ylä-
Herttuala and co-workers studied arteries of Finnish children, and showed that the concentration of arterial 
CEs increases from birth to 15th year at a constant rate, and that the constant-level content of cholesteryl 
oleate suggests that the lipid is derived directly from lipoproteins and not synthetized in the arterial wall. 
Later, Torzewski and co-workers studied aortas of a similar group of children by immunohistochemistry and 
histological stainings for proteoglycans and lipid-rich areas. According to their findings, in arteries of 
children below 1 year, the intima was thin and contained ample amounts of apoB-100, however they found 
only a few lesions that stained with lipophilic Sudan IV-stain. In the aortas of children between 1–5 years, 
intima was already thickened, but very little apoB-100 was found, and no lipid rich areas staining with Sudan 
IV-stain were found. In aortas of the children from age 5 to 15, apoB-100 was found also in much deeper 
layers of thickened intima (Torzewski et al., 2009). In an older group of patients (ages 7—49), Nakashima 
and co-workers (Nakashima et al., 2007) showed with immunohistochemistry for apoB-100 and lipid 
stainings that the extracellular lipid starts to accumulate deep in the intima near the internal elastic lamina 
already in very early stages of atherosclerosis. Only later, when the fatty streaks with heavy intracellular 
lipid accumulation start to develop, macrophages enter the scene (Nakashima 2007). The heaviest lipid 
accumulation is found in the atheroma, and at this stage, also macrophages are found close to the deep lipid 
accumulation site (Nakashima 2007). 
Cholesterol crystals 
Unesterified cholesterol is derived from enzymatic hydrolysis of esterified cholesterol from the core of 
lipoprotein particles. It can also be derived from cholesterol-rich erythrocyte plasma membranes, after 
extravasation of erythrocytes from leaky neovascular capillaries in an advanced atherosclerotic plaque 
(Virmani et al., 2005), and from cholesterol-containg lipid droplet-loaded macrophages, which are able to 
transfer unesterified cholesterol to extracellular space (Kruth et al., 2001; Ong et al., 2010). Unesterified 
cholesterol will form crystals when it reaches the critical concentration (Katz, Shipley, and Small, 1976; 
Konikoff et al., 1992). The critical concentration of cholesterol depends on other lipids available: if the 
solution contains enough phospholipids, they help solubilizing cholesterol up to 33 mol % concentration in 
aqueous solutions, and CEs can solubilize cholesterol up to 8 mol % (Katz, Shipley, and Small, 1976). 
Guarino and co-workers demonstrated that cholesterol crystals can be generated in vitro from lipoprotein 
particles by pretreating LDL first with cholesteryl esterase and then hydrolyzing it with SMase (Guarino, 
Tulenko, and Wrenn, 2004). They also suggest that a prerequisite for crystallization is LDL aggregation, as a 
nucleation center is required for crystals to form. In atherosclerotic lesions, cholesterol crystals can exist both 
intracellularly (Klinkner et al., 1995; Pasquinelli et al., 1989; Tangirala et al., 1994) and extracellularly 
(Bocan, Schifani, and Guyton, 1986; Guyton and Klemp, 1989). In the intracellular compartment, that is, in 
the foam cells, the cholesterol containing lipoproteins and modified lipoprotein-derived particles that the 
cells have taken up, are hydrolyzed in the lysosomes by LAL (Brown, Ho, and Goldstein, 1980). 
Fatty streaks seldom contain cholesterol crystals, while in the more severe lesions they are frequently found 
(Katz, Shipley, and Small, 1976). While in atherosclerotic arterial wall the cholesterol crystals are plentiful 
(Figure 13), in human stenotic aortic valves they are perhaps not found as often as in atherosclerotic arteries 
(Foreman and Fulkerson, 1987; Kuusisto et al., 2005). However, in bioprosthetic valves crystals may 
develop in the course of time: Price and co-workers presented a case, where a bioprosthetitc aortic valve was 
replaced after 21 years, and the leaflets were filled with crystallized cholesterol (Price et al., 2007). In animal 
models of atherosclerosis, however, aortic valves are shown to develop cholesterol crystals (Duewell et al., 
2010). 
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Foam cells 
Extrahepatic cells take up native LDL via LDL receptors, which are downregulated in the presence of 
excessive LDL (Brown, Dana, and Goldstein, 1973; Goldstein and Brown, 1977) (Figure 14). Thus, this 
physiological uptake does not lead to foam cell development. Macrophages have another set of receptors for 
clearing oxidized, modified, and damaged lipoproteins (Figure 14). Scanvenger receptors, CD36 SR-A and 
SR-B recognize oxidized and enzymatically modified LDL and sequester it into lysosomes for degradation. 
However, as shown in the thin inflamed walls of human intracranial arterial aneurysms, partly undegraded 
oxidized LDL is retained in the lysosomal compartment or other intracellular compartments of the 
macrophages suggesting that oxidized LDL does not degrade well in the lysosomes (Ollikainen et al., 2016), 
as cholesterol in oxidized LDL is not accessible to re-esterification by the cytoplasmic acyl-CoA:cholesterol 
acyltransferase-enzyme (ACAT) (Zhang, Basra, and Steinbrecher, 1990). While uptake of native LDL by 
LDL receptor is downregulated by high intracellular cholesterol concentration, uptake via scavenger 
receptors is not inhibited by the internalized cholesterol. The receptors also scanvenge otherwise modified 
lipoproteins, which become quickly degraded in the lysosomes. Resulting unesterified cholesterol is either 
transported for use of membranes or released from the cell. The unesterified cholesterol that is not used for 
the cell can be effluxed to HDL for example via ATP-binding cassette transporters A1 and G1 (ABCA1 and 
ABCG1) (Lee-Rueckert, Escola-Gil, and Kovanen, 2016). Since accumulating unesterified cholesterol would 
induce apoptosis of macrophages (Yao and Tabas, 2000), unesterified cholester in the cell is re-esterified by 
acetyl-coenzyme A acetyltransferase (Brown, Ho, and Goldstein, 1980) and it is stored as CE-containing 
intracellular lipid droplets (Figures 13 and 14). ACAT has a preference for oleic acid as the fatty acid 
substrate (Chang et al., 2010), and so the intracellular lipid droplets contain largely cholesteryl oleate. Also 
the protein moiety of lipoproteins, apoB-100, is degraded by lysosomal proteases such as various cathepsins 
(Linke et al., 2006) and the liberated individual amino acids and small peptide fragments are transported to 
the cytosol. The degradation of apoB-100 is inhibited in mouse macrophages in vitro by oxidized LDL 
phospholipids, which results in filling of the lysosomes with only partially degraded apoB (Itabe et al., 
2000). In vitro experiments have shown that variously modified lipoproteins are extremely susceptible to be 
taken up by macrophages (Aviram and Maor, 1992; Hoff, O'Neil, and Cole, 1991), as are the remnant 
lipoproteins (Elsegood et al., 2001; Yu and Mamo, 2000). Foam cells can be generated both from 
macrophages and smooth muscle cells (Allahverdian, Pannu, and Francis, 2012). In smooth muscle cells 
cholesterol efflux is less effective than in macrophages as ABCA1 is less expressed in smooth muscle cells 
compared to myeloid-origin cells (Allahverdian, Pannu, and Francis, 2012). Also dendritic cells have been 
shown to accumulate lipid droplets in hypercholesterolemic mice (Paulson et al., 2010). 
 
Figure 13. Foam cells and 
cholesterol crystals in a human 
carotid artery intima. Foam cells 
are lipid droplet filled cells that can 
be derived from macrophages or 
smooth muscle cells. 
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Stary describes foam cell formation as a key feature of a "fatty streak" in atherosclerotic arteries (Stary et al., 
1994a). Foam cells start accumulating in the intima only after the lipoprotein-derived lipids already have 
accumulated in the intima (Nakashima et al., 2007). The density of macrophages increases as the intima 
thickens. Foam cells are found also in the stenotic aortic valves, although at a lesser density distribution than 
in the atherosclerotic artery intima (Otto et al., 1994; Syväranta et al., 2014). Both macrophage-derived and 
smooth-muscle cell derived foam cells are found in atherosclerotic lesion (Allahverdian, Pannu, and Francis, 
2012) and in the stenotic valves (Latif et al., 2015). Lysosomal degradation of ox-LDL in cultured mouse 
macrophages and in a human cell line THP-1-macrophages is compromised compared to that of acetyl LDL 
or native LDL (Hoff et al., 1993; Yancey and Jerome, 2001). Also the lectin-like oxidized LDL receptor 
LOX-1 is expressed in macrophages and mediates the uptake of oxLDL by these cells (Pirillo, Norata, and 
Catapano, 2013).  
 
 
 
 
 
 
 
 
 
 
Inflammation in atherosclerosis and aortic stenosis 
Inflammation is considered as a degenerative factor atherosclerosis. Initially, macrophages perform 
reparative measures: they start clearing excessive extracellular lipid. However, because this is an 
overwhelming task, a vicious circle ensues and inflammation starts to deteriorate the intima. As Nakashima 
showed,macrophages only enter the intima after lipid has already accumulated and retained in the aortic wall 
(Nakashima et al., 2007) and inflammation is likely a response to retention of lipoproteins and their 
modifications. Inflammatory cells, such as T-cells (Zhou, Stemme, and Hansson, 1996), macrophages 
(Nakashima et al., 2007; Olsson et al., 1994), and mast cells (Kaartinen, Penttila, and Kovanen, 1994) 
accumulate in the thickened intima that is filled with extracellular lipid particles. The modified, oxidized or 
lipolyzed lipoproteins can attract T-cells (McMurray, Parthasarathy, and Steinberg, 1993) and monocytes 
(Quinn, Parthasarathy, and Steinberg, 1988). Macrophages and T-cells secrete cytokines, such as IL-1β, IL-
18, and γ-interferon, which can induce remarkable rearrangement of the intimal tissue by activating resident 
smooth muscle cells or endothelial cells to produce extracellular matrix (Pober and Tellides, 2012), or by 
inducing secretion of enzymes that can degrade the collagen and elastic laminae in the inflamed 
atherosclerotic lesions (Galis et al., 1995; Galis et al., 1994). Matrix remodeling in aortic valve leaflets it is 
driven by mast cell-derived proteases (Helske et al., 2006a), MMPs (Kaden et al., 2005a), and cytokines like 
TNFα that increase cell proliferation (Kaden et al., 2005b). Macrophages and T-cells start to accumulate 
already in early stages of aortic stenosis (Otto et al., 1994). 
Figure 14. A schematic figure of foam 
cell formation. Modified from Brown 
and Goldstein 1983 and 1976 (Brown and 
Goldstein, 1983; Brown and Goldstein, 
1986) 
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In aortic valves IL-1β has been shown to activate aortic valve interstitial cells into an inflammatory 
phenotype (Kaden et al., 2005a; Kaden et al., 2003; Nadlonek et al., 2013). Bone formation in stenotic aortic 
valves is associated with inflammatory cell accumulation, and T- and B-cells and mast cells are found in the 
same areas with lamellar bone, so providing a link between inflammation and calcification at the cellular 
level (Helske et al., 2004; Mohler et al., 2001; Olsson et al., 1994). IL-1β has been found to stimulate MMP-
expression in macrophages: Stimulation of collagenolytic MMP1 production by endothelial cells may lead to 
decreased content of collagen in the shoulder of an atherosclerotic plaque (Huang, Mironova, and Lopes-
Virella, 1999) and thus weaken the plaque stability and functionality. 
Several lipid hydrolysis products are proinflammatory. LPC, a product of phospholipid hydrolysis, can 
induce IL- 1β secretion by monocytes (Liu-Wu, Hurt-Camejo, and Wiklund, 1998) and upregulate the 
expression of adhesion molecules on the endothelium (Kume and Gimbrone, 1994), and so contribute to the 
accumulation of inflammatory cells. Free fatty acids are found to amplify inflammation in monocytes, 
especially in type 2 diabetes, and this they do by increasing expression of toll-like receptors (TLRs), nuclear 
factor- κB, monocyte chemoattractant protein-1 and IL-1β (Dasu and Jialal, 2011). Cholesterol crystals have 
recently been found to possess proinflammatory potential, as they can activate the inflammatory complex 
called inflammasome in macrophages and thereby induce IL-1β-secretion by these cells (Duewell et al., 
2010; Rajamäki et al., 2010)  
Inflammasome 
Innate immunity is a first-in-line defence system that immune system cells use against any harmful stimuli. 
Such stimuli can be pathogens, dead cells and cell debris, and various irritative agents or foreign bodies. 
Inflammasome is considered as a driving factor in many autoimmune conditions, such as in gout and 
rheumatoid arthritis. In the innate immunity cells, there is a censor system, that consist of cell membrane 
receptors and an intracellular protein complex called inflammasome. The inflammasome consists of multiple 
proteins that form a large complex when activated. Several types of inflammasomes have been described, but 
NLRP3-inflammasome complex is the most relevant one for atherosclerosis. The core of the complex is 
NLRP3-protein (nucleotide-binding domain leucine-rich repeat containing (NLR) family, pyrin domain 
containing 3) which complexes with adapter protein (apoptosis-associated speck-like protein containing 
caspase activation and recruitment domain (ASC) (Stutz et al., 2013). NLRP3-complex recruits procaspase-1 
which then becomes cleaved to mature caspase-1, which, in turn, is able to cleave pro-IL-1β and pro-IL-18 
into their biologically active forms that can be secreted (Ghayur et al., 1997; Thornberry et al., 1992). 
Inflammasome requires two signals for its activation. The first one, a priming signal, (Latz, Xiao, and Stutz, 
2013) is mediated via pattern recognition receptors, such as the Toll like receptors (TLRs), that recognize 
either pathogen associated molecular patterns (PAMPs) or damage associated molecular patterns (DAMPs), 
(Bauernfeind 2009). The primining signal induces transcription of NLRP3 and of pro-IL-1β or pro-IL-18. 
For inflammasome complex build-up and subsequent cytokine cleavage, a second stimulus is required. The 
second stimulus can be an endogenous one, like extracellular ATP derived from damaged cells (Ferrari 
1997), acidic pH (Rajamäki et al., 2013), or cholesterol crystals in the arterial intima (Duewell et al., 2010; 
Rajamäki et al., 2010), or it can come from outside of the body, like asbestos (Sayan and Mossman, 2016) or 
extremely fine carbon particles (Murphy et al., 2012). Oxidized LDL has been suggested to activate 
inflammasome as Duewell et al demonstrated that it induced IL-1β -secretion by inflammasome activation in 
a mouse model (Duewell et al., 2010). NLRP3 inflammasomes have been found in human atherosclerotic 
coronary arteries (Rajamäki et al., 2016) and carotid arteries (Shi et al., 2015), and the levels of expression of 
the key NLRP3 inflammasome components correlate with the severity of atherosclerosis.  
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Aims of the study 
The extracellular lipid in aortic stenosis and atherosclerosis has been considered as a rather unreactive debris 
that accumulates and is cleared by macrophages. Also, the spatial distribution of diffeent lipid groups in the 
extracellular lipid has been unknown. This gave the rationale to examine the extracellular lipid more closely. 
More specifically, the aim was to investigate the following: 
1. To examine the spatial distribution of different classes lipids and species therein in the intima, and to 
visualize the spatial arrangement of cholesterol crystals and the lipid species in atherosclerotic arterial intima 
and the underlying media. 
2. To isolate and characterize the extracellular lipid particles from stenotic aortic valves and from carotid 
atherosclerotic lesions in order to examine the chemical and physical properties as well as modifications of 
lipoprotein particles that may lead to generation of such particles. 
3. To examine the effect of the extracellular lipid particles on inflammasome activation in macrophages. 
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Methods 
Table III. Methods used in the studies 
Method used Study  
Mass spectrometry, ESI-MS I, III  
Mass spectrometry, ToF-SIMS II  
Liquid chromatography-mass 
spectrometry III 
 
Thin layer chromatography I (Lähdesmäki et al., 2009) 
 Electron microscopy, 3-view  III (Belevich et al., 2016) 
Electron microscopy, tomography III (Mastronarde, 2005) 
Electron microscopy, size analysis I  
Circular dichroism  III  
Dynamic light scattering I, III  
   
Rate zonal ultracentrifugation I, III  
Western blot I, III  
Lipid extraction I, II, III 
(Folch, Lees, and Sloane Stanley, 1957) 
Cell culture, macrophages 
differentiated from human 
primary peripheral blood 
monocytes 
II, III 
(Nakanishi et al., 2009) 
Statistical methods, multivariate 
analysis I,II,III 
 
   
Immunohistochemistry    
ApoB-100 II, III  
ApoA-I III  
ApoC-III III  
ApoE III  
   
CD31 II  
CD34 II  
CD163 II  
Glycophorin A II  
   
ELISA    
ApoB-100 I,III  
Apo-E I  
IL-1β III  
 
Extracellular lipid particle isolation 
Extracellular lipid particles were isolated from human aortic valves and human carotid arteries. The aortic 
valves were acquired from aortic valve replacement surgery and the carotid artery sections were from 
endarterectomy surgery. All patients had signed an informed consent form prior to the operation. For each 
isolation, one whole valve leaflet was used, and in case of carotid arteries, pieces of several carotid arteries 
were combined for a pool, which will be referred to as “sample” in the text. Prior to the isolation, tissues 
were stored at-80 °C. The tissues were ground in liquid nitrogen into fine particles with mortar and pestle, 
after which salt-based isolation buffer (0.01 M Tris, 0.15 M NaCl, pH 7.4 and 0.01 M Tris, 1.5 M NaC) 
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containing 0.02 mM butyrated hydroxytoluene, 0.1 % EDTA, 0.01 % NaN3, and a protease mix was applied 
onto them. The sample was gently agitated in isolation buffer for 10 minutes, and centrifuged for 30 min at 
10 000 g, +4 °C. The supernatant containing extracellular lipid particles was collected into a fresh tube (on 
ice) and high salt buffer (1.5 M NaCl) was applied onto tissue homogenate. After gently agitating the sample 
for 10 minutes, the tube was placed in an ultrasonic bath in ice water for 10 minutes to detach remaining 
lipid particles from the extracellular matrix. The samples were recentrifuged for 30 minutes at 10 000 g, +4 
°C. The supernatants were collected and combined with the first supernatant.  
The density of the sample was set to 1.063 with D2O-based buffers (0.1 M Tris, 0.15 M NaCl in D2O, d = 
1.116 g/ml and 0.1 M Tris, 0.15 M NaCl in H2O, d = 1.006 g/ml, both containing 0.1 % EDTA) and 
ultracentrifuged for 24 h in a SW41Ti rotor (gmax 288 000 x g, 40 000 rpm) at +4 °C, and the lipid particles 
were collected from the top of the tube. The samples were stored at +4 °C until further analysis. 
Plasma lipoproteins 
Human plasma lipoproteins were isolated from plasma that was obtained from healthy volunteers (Finnish 
Red Cross Blood Service, Helsinki, Finland). Plasma VLDL (d < 1.006 g/ml), IDL (d = 1.006-1.019 g/ml), 
and LDL (d= 1.019-1.050 g/ml) vere isolated by sequential ultracentrifugation in the presence of 3 mmol/l 
Na2EDTA (Havel, Eder, and Bragdon, 1955; Radding and Steinberg, 1960). EDTA and 100 μg/ml of 
gentamicin sulfate (Lonza, Basel, Switzerland) were added to plasma, and the plasma was centrifuged at 40 
000 rmp (rotor 50.2 Ti, gmax 302 000) at +4 °C for 24 h. The VLDL fraction was collected from the top of 
the tube, and the density of the remaining plasma was set to 1.019 g/ml with KBr, and the density-adjusted 
plasma was then centrifuged at 40 000 rpm for 24 h. After that, IDL fraction was collected from the top of 
the tube. Density of the remaining plasma was set to 1.050 g/ml with KBr, and the density-adjusted plasma 
was centrifuged at 40 000 rmp for 24 h, after which the LDL fraction was collected similarly as the VLDL 
and IDL fractions. LDL fraction was "washed" by recentrifugintg it at a density of 1.063 g/ml. The collected 
top fraction of the tube was dialyzed against 1 mM EDTA-150 mM NaCl, pH 7.4, after which the protein 
concentrations of lipoproteins were measured by the method of Lowry (Lowry et al., 1951), using bovine 
serum albumin as standard. 
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Methods used in the thesis 
Lipid analysis  
Thin layer chromatography 
Thin layer chromatography (TLC) separates lipid classes by their ability to bind to the stationary phase 
(silica plate) and to travel with the mobile phase, depending on their polarity. The "neutral" lipids such as 
free fatty acids, cholesterol, CEs and TAGs, that require adequate proportion of hydrophobic solvents for 
their mobility in the stationary phase, and the phospholipids, such as PCs, LPC s, and SMs require larger 
proportions of hydrophilic solvents in the mobile phase. If the degree of hydrophobicity of individual lipid 
species in one lipid class is large enough, the technique is able to separate the species, provided that suitable 
mobile phase and long enough travel time PC on the stationary phase are used. Usually it is enough to 
separate only the main lipid classes. Modern High Performance TLC (HPTLC) allows quantitative analysis if 
a suitable set of lipid standards is used. Thus HPTLC serves well in quantification of the proportions of 
different lipid classes, and particularly the proportions of unesterified and esterified cholesterol. Alcoholic 
cholesterol does not ionize well and would require derivatization prior to lipid mass spectrometry, and 
therefore, in this thesis, HPTLC was an useful technique in measuring the proportion of unesterified 
cholesterol in the mixture of tissue lipids. From the same samples, it was possible to gain information of the 
ratio of glycerophospholipids to cholesterol. However, to gain more detailed information of different species 
within lipid classes, another analysis method was needed.  
Mass spectrometry 
While HPTLC was an useful method in analyzing the proportions of different groups, mass spectrometry 
provided detailed information of different species within lipid groups. In this thesis, two different mass 
spectrometry methods were used: electrospray ionization (ESI) to analyze lipids and proteins and secondary 
ion mass spectrometry to analyze lipids on the cryosection surfaces.  
In mass spectrometry, analytes are given either a positive or negative charge by ionization and separated by 
their mass and charge (m/z) ratio. The most electronegative molecules or side chain groups are the most 
easily ionized. Unorganic molecules are ionized according their capability to accept or lose 
protons/electrons. Lipids usually acquire or lose only one electron while proteins can get several charges, 
depending on their composition.  
Electrospray ionization 
In electrospray ionization (ESI) the analytes in organic solution are sprayed through a narrow capillary in a 
high voltage field gas and the formation of the fine spray is supported by hot gas stream. The sprayed 
analytes in the liquid droplets become charged, and as the solvent evaporates, charges densify, and repel each 
other, and optimally only the charged analytes end up in the vacuum chamber and to the mass analyzer. 
(Figure 15). ESI-mass spectrometry (ESI-MS) is considered as a soft ionization method and thus is suitable 
for lipids since it does not extensively fragment the lipids (Brügger et al., 1997). By using suitable standards 
ESI-MS can be used for a semiquantitive analysis. True quantification requires numerous lipid standards 
with acyl chains having different chain lengths and degree of unsaturation stages. The ions can be either 
protonized or deprotonized to form positive or negative ions, respectively (Thomson and Iribarne, 1979). ESI 
can be combined with different mass analyzers, for example ion trap, quadrupole, and time of flight (TOF)-
analyzer 
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The structural characteristics of lipids affect their ionization: PC, SM, CE, and TAG all can be charged 
positively when ammonium is supplied, and thus are analyzed in the positive ion mode. Fatty acids, PS, and 
PI rather lose protons and are analyzed in the negative ion mode. The PE is zwitterionic and both ionization 
modes can be used. In ESI-MS, the efficiency of ionization drastically depends on the lipid chain lengths and 
degree of unsaturation (Brügger et al., 1997). For example, even if equimolar amounts of two PCspecies are 
administered to the mass spectrometer, species with the shortest acyl chains or with the highest degree of 
unsaturation gain the highest spectral peak intensities (Brügger et al., 1997). The same applies to CE, SM, 
and TAG species. Hydrophobic, or nearly hydrophobic lipids, such as unesterified cholesterol with a large 
bulk of nonpolar sterol backbone, ionize poorly and are not readily detectable with ESI-ionization mass 
spectrometry without derivatization (Liebisch et al., 2006). To enhance ionization of lipids, their different 
derivatives or adducts can be used; in ESI-MS ammonia is frequently added to produce ammonium-adducts 
(Duffin 1991, Crawford 1986). 
TOF-SIMS 
Time of Flight Secondary Ion Mass Spectrometry (TOF-SIMS) was originally used to analyze surfaces in 
metallurgy. Recently, it has also been adapted to analyze biological samples, especially lipids, as the mass-
charge ratio range of TOF-SIMS is well suited to small molecules and their fragments. In this thesis TOF-
SIMS was used to analyze spatial distribution of lipids of cryosections of coronary arteries, as with SIMS 
methods, analysis directly from surface is possible. Originally only the secondary ions from smallest 
molecules like amino acids, drugs, vitamins, and small peptides could be collected (Benninghoven and 
Sichtermann, 1978), but later when the energy of the primary ions could be adjusted to better suite organic 
samples, also larger molecules, such as lipids could be detected (Walker, 2008). In the SIMS, samples are 
placed in a vacuum and bombarded with multiatom primary particles consisting of bismuth (Bin+), gold 
(Aun+) or fullerene (C60+) to desorb the outmost molecule layer of the tissue surface (Benninghoven, 1994; 
Passarelli and Winograd, 2011; Walker, 2008). The detached material - secondary ions - are then collected 
into the mass analyzer. A full mass spectrum can be acquired from each analyzed voxel, with sub-
micrometer resolution. As each primary ion beam only erodes the surface by depth of 1-2 nm, the analysis 
can be repeated, so that both positive and negative ion spectra can be collected from every voxel. When the 
mass spectra are collected sequentially in a grid of voxels, by combining the spectra from every voxel, it is 
possible to create surprisingly detailed images of spatial distribution of any analyte on the surface, and both 
Figure 15. Electrospray ionization. The tip of the ionization probecapillary which is at positive 
voltage, and from which the positively ionized analytes are repelled with the solvent. Droplets of 
solvent containing the ionsare reduced in size due to evaporating gas stream and in optimal case the 
ionized analytes are emitted and carried into the mass analyzer parts in vacuum. 
Vacuum 
Ambient pressure 
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the mass spectra and the image generated from the combinations of several different spectra can be used to 
obtain even more detailed information of the samples. Initially, the images were two-dimensional, but as the 
primary ion sources developed into less damaging cluster ions, also three-dimensional imaging has become 
possible, as several layers of a sample can be imaged (Walker, 2008).  
TOF-SIMS is hardly a method easily accessible for every laboratory, as the equipment is expensive. The 
samples must be sectioned and mounted on special conductive silica plates and thoroughly dehydrated, but 
otherwise no extensive preparation is necessary. Target analytes break due to the high energy impact of the 
primary ion. Rhe sensitivity of SIMS is reduced at over m/z 1000, due to molecule fragmentation or poor 
ionization of large molecules. Therefore,TOF-SIMS suitsbest for small molecules, such as lipids, and is less 
suitable for studying proteins with high mass (Chughtai and Heeren, 2010; Passarelli and Winograd, 2011). 
In lipid ToF-SIMS the challenges are similar to those in ESI-MS-analysis. Lipid species that aquire or lose 
protons easily, as many phospholipids do, tend to ionize more easily than hydrophobic of nonpolar lipids, 
such as cholesterol CEs (Liebisch et al., 2006). Thus the intensities of phospholipids are seemingly higher 
than those of cholesterol and CEs, even if, for example in atherosclerotic arteries, the actual amounts of these 
neutral lipids is extremely high. Furthermore, in TOF-SIMS all ions are desorbed simultaneously, and so the 
matrix effects created by the better ionization efficiency of the phospholipids suppress the intensities of 
neutral lipids. This can be also seen when higher spatial resolution is selected for better image resolution: the 
smaller the voxel area is, the smaller is the amount of desorbed and ionized molecules, and the intensities of 
neutral lipids are suppressed even more than in the high mass resolution mode (Chughtai and Heeren, 2010; 
Passarelli and Winograd, 2011). 
Protein analysis 
Circular dichroism 
To analyze the conformation of the protein moiety of the extracellular lipid particles, circular dichroism was 
used. Secondary structure of proteins consists of α-helices, ?-sheets and random coils. In circular dichroism, 
these secondary structures are analyzed based on their ability to absorb and to turn polarized light in a plane 
(Beychok, 1966; Beychok, 1968). With circular dichroism it is possible to show the differences in the 
secondary structures: a protein consisting mainly of α-helix has a different spectrum from a protein rich in β-
sheet or random coil (Beychok, 1966; Kelly and Price, 2000; Tiffany and Krimm, 1969). The method is 
useful in showing possible changes in protein structure under different conditions. Usually the structure of a 
protein is a combination of several different types of secondary structures, and, accordingly, circular 
dichroism spectrum is a combination of circular dichroic curves for the α-helix, β-sheet, and random coil 
conformations (Beychok, 1966; Greenfield and Fasman, 1969). In a mixture of proteins, such as the 
extracellular lipid particles measured in this thesis, all components contribute to the circular dichroism 
spectrum (Beychok, 1966), so for a mixture of different proteins and these other proteins may interfere or 
add to the spectrum (Beychok, 1968; Kelly, Jess, and Price, 2005). For analysis and to get reliable results of 
the protein structure, it is necessary to purify the protein from excess salt or chaotropic elements such as 
urea, since these compounds affect the structure of protein (Kelly, Jess, and Price, 2005).  
Isolation and analysis of extracellular lipid particles 
Isolation of the extracellular lipid particles  
Isolating extracellular lipid particles from atherosclerotic tissues can be achieved by many different methods, 
depending on the required material quality. Common feature to the methods is that the tissue is minced into 
pulp in isotonic buffer containing EDTA. Several different methods have been used to homogenize the 
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tissues. In some studies tissues have been homogenized with an electronic homogenizer (Polytron) to obtain 
fine enough pulp to enhance sufficient lipid particle isolation (Hoff and Clevidence, 1987; Hoff and Gaubatz, 
1982; Hoff and Morton, 1985). Others have relied on glass homogenizer (Li et al., 2005), tissue choppers 
(Ylä-Herttuala et al., 1988), or scissor mincing (Chao et al., 1988; Chao et al., 1990; Li et al., 2005). In this 
thesis tissue homogenization in liquid nitrogen was used. In this method the tissue was kept frozen under 
liquid nitrogen and it became thus brittle and was easily broken with mortar and pestle. Heavily calcified 
tissues, such as stenotic aortic valves, and sometimes also carotid arteries, can otherwise be difficult to 
homogenize. As the tissues are kept under nitrogen, also the effect of oxygen is minimized. The 
homogenization method has, however, less effect on the result than the next isolation step. That step 
determines the limits of the further analysis. 
Isolation of the lipid particles from tissues can be carried out by affinity or size exclusion colums, or by a 
density gradient centrifugation. Affinity columns isolate particles containing a specific component, such as 
apoB-100, which, on the other hand, limits the gain to the particles in which the antigenicity has been 
preserved. Size exclusion or gel filtration columns limit the size of the particles acquired. The smallest 
particles flow through the column, and the pore size of the column defines the largest size that can be passed 
through. Ultracentrifugation of the tissue extracts separates the particles according to their density, which is 
dependent on the composition of the particles. (Redgrave, Roberts, and West, 1975). This method was used 
in this thesis, as for the analyses, all lipid particles that had lower density than 1.063 g/ml were collected so 
that no part of the extracellular lipid particles were excluded. The density gradient ultracentrifugation was 
also used to concentrate the extracellular lipid particle preparate. When the centrifugation procedure is 
carried out with KBr solutions, the samples may require dialysis against a low-salt solution. If dialysis is not 
suitable for the overall method, the density can be achieved also by using D2O-based salt buffers in 
combination with H2O-based salt buffers. In this thesis, D2O-based buffer system was used in separation, as 
with D2O, dialysis was not necessary. With minimizing the amount of purification steps, possible loss of 
sample was avoided. 
Size analysis 
Electron microscopy measurements 
For measuring the size of the particles, several different methods are available. With electron microscopy 
images, sizes of the particles can be accurately measured (Hakala et al., 1999; Paananen and Kovanen, 
1994); given the scale bar is correct (Forte 1972). From a thin section and a negative staining, only two 
dimensions of the particles are taken into account, i.e. the exact length of the cross section of the particles 
can be detected. If the particles in solution are applied to a grid and dried onto it, it is possible to try to detect 
aggregation of the particles. However, it is not possible to separate the genuine aggregates from artefactual 
aggregates generated during treatment of the samples.  
Electron tomography and 3-view electron microscopy 
Electron microscopic tomography (EM tomography) and 3-view EM are methods with which it is possible to 
obtain three-dimensional images of the ultrastructure of cell organelles and various tissue structures 
(Skoglund et al., 1986). For the EM tomography, the images are constructed from semi-thick sections (250 
nm) that are cut out of resin-embedded blocks. The specimens are imaged and composed using a software to 
create three-dimensional images (Kremer, Mastronarde, and McIntosh, 1996; Mastronarde, 2005). The 
outlines of the particles are traced and the images are visualized using the MIB-software (Belevich et al 
2016). In EM tomography, the semi-thick section is imaged from several different angles, which can bring 
out even the finest details of subcellular structures and even viruses. Here, tomography was utilized to verify 
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particle fusion. Detecting the actual fusion of the particles requires similar high resolution, as actual absence 
of any membrane between two apparently fusing particles has to be reliably detected. The 3-view EM is 
essentially scanning electron microscopy, where several hundred layers of a resin-embedded sample are 
scanned and combined as a stack with a software. With the 3-view EM, larger areas can be imaged than with 
tomography, but in process of sectioning the tissue in 40 nm intervals, some fine structures, such as the 
smallest lipoproteins, may be lost.  
Dynamic light scattering 
Measuring size of the particles within the size range of 10 to 1000 nm cannot be performed with visual 
methods except with electron microscopy. Unfortunately, sample preparation for electron microscopy is time 
consuming and demanding. Measuring of a large number of samples at one time is more efficient with 
dynamic light scattering (Sartor, 1970). This method relies on several photons scattering from a particle, and 
on detecting the diffusion rate of particles of different sizes (Goldberg, 1996). Small particles tend to move 
randomly more and faster than large particles do. The particles or particle aggregates rotate around, and the 
non-spherical pieces are approximated as spheres according to their largest dimension. This method does not 
separate large particles from aggregates. In the current study, dynamic light scattering was a suitable method 
to useas the sample can be recovered from the cuvette for future analyses, and multiple samples could be 
measured relatively fast.  
Rate zonal ultracentrifugation 
The size of the particles can be determined using a density gradient in rate zonal ultracentrifugation, where 
the particles float according to their respective sizes. Thus, with rate zonal ultracentrifugation it is possible to 
purify and concomitantly collect particles of a certain size and shape (Maskowicz, 1991). In this method, a 
step-wise gradient of buffers in different densities is built, and the sample is loaded in the bottom of the tube, 
with density set at the highest value. During centrifugation, the particles with a certain size travel through 
different densities forming distinctive layers (Maskowicz, 1991). The particles are separated by both their 
size and their ability to sediment (Anderson, 1966). The method produces a reproducible size distribution 
pattern of the particles, and therefore can be used as a method to analyze e.g., RNA or DNA (Lin et al., 
2013), bacteria (Maskowicz, 1991) or proteins like different lipoproteins (Polacek, Byrne, and Scanu, 1988). 
Particles that are uniform in size, such as LDL-particles, tend to float in a narrow band (Polacek, Byrne, and 
Scanu, 1988). With rate zonal ultracentrifugation, it is possible to separate modified lipoproteins from native 
lipoproteins, as the lipolytically modified lipoproteins float in different manner comparerd to the native 
lipoproteins (Pentikäinen, Lehtonen, and Kovanen, 1996), although lipoproteins, size of which do not change 
in modifications, (e.g. LDL modified with elastase) float similarly as the native LDL (Polacek, Byrne, and 
Scanu, 1988). The largest particles are found in the top of the ultracentrifuge tube. In this thesis, rate zonal 
ultracentrifugation was used to separate freshly isolated extracellular lipid particles in groups of different 
size. From the different size groups, it was then possible to analyze several characteristics, such as lipid and 
protein compositions of the particles. 
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Materials  
Biological material 
Ethics statement 
The use of human material conforms to the principles outlined in the Declaration of Helsinki. The studies 
were approved by the Ethics Committee of Helsinki University Central Hospital and the National Authrority 
for Medicolegal Affairs. All surgical patients (patients undergoing cardiac valve replacement, heart 
transplant operation, or endarterectomy operation) had signed an informed consent documents. Human 
plasma and buffy coat preparations were obtained from healthy blood donors, and they were by-products 
from the preparation of blood products for clinical use. Use of the for lipoprotein isolation and monocyte 
preparation was approved by the Finnish Red Cross Blood Service. 
Clinical characteristics of the patients  
Table IV Patients with aortic stenosis (Study II) 
Age Sex  
M/F 
BMI Diagnosis Clinical history Statin  Smoking Dys- 
lipidemia 
Valve leaflet 
weight (mg) 
67 F 29 AS DM + - + 1892 
82 F 22 AS+AI HT, DM - - + 633 
73 M 23 AS DM + + + 605 
70 F 26 AS - - - - 1773 
81 M 24 AS HT, KD - - - 2067 
74 M N/A AS HT + - + 930 
58 M 28 AS HT, DM, TIA/stroke + + + 1876 
75 F 30 AS - - - + 1476 
80 M 22 AS HT + + + 1393 
61 F 23 AS - - + - 1520 
70 F 31 AS TIA/stroke + - + 659, 767 
53 M 22 AS - + + + 1950, 1080 
53 M 27 AS HT + - + 1827, 2367 
64 M 37 AS DM - - + 1668 
86 F N/A AS - - - N/A 852 
72 F 21 AS HT + - + 779 
43 M 37 AS - + - + 4367 
37 M 27 AS+AI HT - + + 295 
86 F 22 AS+AI - - - - 2308 
75 F 30 AS - - - - 392 
65 F 28 AS+AI - - - N/A 778 
76 F 33 AS HT, DM + - + 1321 
63 M 31 AS HT + + + 1594 
AS=Aortic stenosis, AI=aortic insufficiency, DM=diabetes mellitus, HT=Hypertension, KD= kidney disease, TIA=transient ischemic 
attact,  
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Table V Control patienst with no aortic stenosis (Study II) 
Age Sex  
M/F 
BMI Diagnosis Clinical history Statin  Smoking Dys- 
lipidemia 
Valve leaflet 
weight (mg) 
69 M 25 AI HT - - - 214 
65 M 30 AI KD, lung disease - - - 290 
79 F 27 AI HT, DM, KD - - - 173 
62 F 25 AI HT - - - 135 
71 M 21 AI HT, KD - + + 352 
55 M 23 AI HT - - - 186 
58 M n/a Dil CMP KD - - - 248 
63 F 33 ICH N/A N/A N/A N/A 270 
58 M n/a CHF TIA/stroke, lung disease + + - 413 
42 M 27 SAH N/A N/A N/A N/A 314 
58 F 59 PE TIA/stroke N/A N/A N/A 201 
64 F n/a Dil CMP - - - - 291 
74 M 26 AMI N/A - N/A N/A 436 
66 F 22 ES N/A N/A N/A N/A 347 
AI=aortic insufficiency, Dil CMP=dilated cardiomyopathy, ICH=intracerebral hematoma, CHF=congestive heart failure, 
SAH=subarachnoid hematoma, PE=pulmonary embolism, AMI=acute myocardial infarction, ES=epileptic seizure, N/A=data not 
available, AS=Aortic stenosis DM=diabetes mellitus, HT=Hypertension, KD= kidney disease, TIA=temporary ischemic attact 
 
Table VI Coronary artery donors (Study I) 
Age Sex  
M/F 
Diagnosis Source of 
coronary 
artery 
Coronary 
artery 
Plaque class 
(Stary et al., 
1994a; Stary et 
al., 1994b) 
Area 
gradings 
59 M Dil CMP Transplant 7LCX I 1,2 
49 M CMP Transplant 1RCA 
6RCA 
I 
IV 
1,2 
3,4 
55 M Cerebral contusion Donor heart 4RCA 
1LCX 
II 
VI 
2 
3,4,5,6 
44 F SAH Donor heart 7LCX III 2,3 
60 M Heart failure Transplant 6RCA VI 3,4,5,6 
35 F SAH Donor heart 6RCA IV 3,4,5 
Dil CMP = Dilated cardiomyopathy, SAH Subarachnoid hematoma, LCX = left circumflex artery, RCA = right coronary artery. 
 
Carotid arteries 
For the analysis, 302 pieces of carotid arteries was used. The samples were anonymous, and no clinical 
details were collected. All patients had undergone a planned endarterectomy operation to remove an 
atherosclerotic plaque from the carotid arteries. 
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Results and discussion 
Accumulation and retention of lipid particles in the arterial intima is considered as the initiation of 
atherosclerosis (Williams and Tabas, 1995). The experiments presented in this thesis are aimed at describing 
the chemical and physical characteristics of the accumulated lipid particles and the pattern of lipid 
distribution in the coronary arteries, and comparing the lipid particles accumulating in aortic valves to the 
lipid particles in carotid arteries and to plasma lipoproteins. In addition to this, the possible effects that the 
extracellular lipid particles may have on development of atherosclerosis are described. In this study the data 
are combined from three different sites of arterial systems that are most susceptible to lipid accumulation: 
coronary arteries, aortic valves, and carotid arteries. Also the possible contribution of the extracellular 
particles on the inflammatory component of atherosclerosis and aortic stenosis was studied.  
For this research, to describe the spatial distribution of lipids, 8 coronary arteries at different stages of 
atherosclerosis were studied. To further analyze the extracellular lipid particles in aortic stenosis and carotid 
artery atherosclerosis, 29 aortic valve leaflets and excised specimens in total from 302 pieces of carotid 
arteries were analyzed. Of the analyzed valves,15 were stenotic and 14 non-stenotic. From the coronary 
arteries, spatial distribution of lipids was analyzed with ToF-SIMS, an imaging mass spectrometry tool. The 
carotid artery intima was imaged with electron microscopy and electron tomography. The lipid particles 
isolated from aortic valves and carotid arteries were analysed with thin layer chromatography, lipid mass 
spectrometry, protein mass spectrometry, Western blotting, ELISA, rate zonal centrifugation, dynamic light 
scattering, circular dichroism.  
Patterns of lipid accumulation in atherosclerosis of coronary arteries (I) 
In this study, lipid accumulation in different stages of human coronary artery atherosclerosis was analyzed 
with time of flight secondary ion mass spectrometry (TOF-SIMS) using cryosections of eight coronary 
arteries. Stary describes atherosclerotic plaques as entities and classifies them according to the most affected 
area (Stary et al., 1994b). However, in this thesis, the plaques were divided into subareas and the 
classifications by American Heart Association and Stary were used as guidelines. The visual data derived 
from photomicrographs, however, does not extend to the chemical data other than histological stainings such 
as Oil Red O or filipin -stainings for neutral lipids or unesterified cholesterol (Kruth, 1984). For more 
detailed data of the distribution of lipids other than cholesterol or neutral lipids other methods, such as 
imaging mass spectrometry, must be used. 
The distributions of fatty acids, different species of cholesterol, phospholipids, iron-ion, and vitamin E were 
determined with TOF-SIMS, and linked with stainings for apoB-100, glycophorin A, CD163-positive 
macrophages, and CD34/31 for neovessel formation of the sequential sections of the same plaques. The 
images generated from the data obtained from TOF-SIMS were also combined to view the spatial 
colocalization of different lipid classes. Finally, the presence of the various lipid classes was compared with 
that of variousproteins that had been visualized with immunohistochemistry.  
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Figure 17. Cholesterol distribution in coronary arteries with a normal intima (A), and in an 
atheroma-stage (B), and an advanced stage atherosclerotic plaque (C). Three (A), six (B), and eight 
(C) areas of interest (500 x 500 μm) were analyzed in three atherosclerotic lesions with ToF-SIMS 
imaging mass spectrometry. Cholesterol is visualized by combination of all cholesterol ion species: data 
from ions m/z 385 and m/z 369 detected with a positive mode MS are combined and overlayed on the 
photomicrographs. A. In the normal coronary artery cholesterol signal can be seen mainly 
periendothelially. Deeper in the intima and in the media or adventitia the signal is much lower 
(circulated areas). B. In the atheroma-stage coronary artery the cholesterol signal seems to be 
accumulating deeper in the intima, close to the media. C. In a coronary artery with a very advanced 
atherosclerotic plaque, cholesterol is accumulated in several layers of a very thick intima 
Figure 16 ToF-SIMS imaging mass spectrometry-generated images of small molecules and lipids 
detected on a coronary artery. Several different ions can be detected simultaneously, and both positive 
and negative mode ions can be detected. Large molecules, such as proteins, fragment and cannot be 
individually identified but small molecules of low molecular weight, such as lipids and vitamin E can be 
recognized. The spatial aggangement of different lipids, such as cholesterol, TAGs, and phospholipids 
can be compared with each other. 
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Imaging mass spectrometry (MS) revealed remarkable differences in spatial distribution patterns of the 
various lipids when thin sections of normal coronary arteries and of coronary arteries with different stages of 
atherosclerosis were compared (Figure 16). Imaging MS revealed that in an atherosclerotic intima, in one 
section of an artery, several different domains with different compositions of lipids can be detected. Next to 
the most affected area rich in cholesterol and phospholipids, there can be a domain that is more fibrotic or 
has less neovascularization and has less cholesterol or contains much less phospholipids. In the healthy 
coronary arteries examined, most of the lipids were unesterified cholesterol and phospholipids, lipid species 
common in cell membranes. In the later stages of atherosclerosis, cholesterol was seen to accumulate, first 
close to the internal elastic lamina, and later also closer to the lumen. Still, even in a very advanced plaque, 
part of the intima may resemble a normal intima with only very minor lipid depositions. Of the detected 
lipids, unesterified cholesterol and CE were directly correlated to the severity of lesions, as PC was inversely 
correlated with the advanced-type lesions. These features of human coronary arteries analyzed by TOF-
SIMS will be discussed in the following chapters in more detail. 
Cholesteryl esters and unesterified cholesterol  
Cholesterol signals 
Cholesterol was detected in several signals in TOF-SIMS. In the positive mode, m/z 385 (cholesterol - H)+ 
and m/z 369 (cholesterol - OH)+ were defined to represent unesterified cholesterol and esterified cholesterol, 
respectively. Using standardized samples of cholesterol and cholesteryl linoleate, the ratio of the two 
cholesterol species (m/z 385 and m/z 369 (ratio 385/369), interpreted as unesterified cholesterol and 
esterified cholesterol, respectively) was found to be 0.3 for unesterified cholesterol and less than 0.05 for 
esterified cholesterol (Study I, Figure 2). Thus, the lower the ratio, the more CE is detected. The ratio 
385/369 is proposed to be a new marker for esterified cholesterol. 
Cholesteryl esters and unesterified cholesterol in the coronary artery sections 
In the normal coronary artery sections in this study, lipids were seen evenly distributed in the intima as well 
as in the media (Figure 17 A). Only near the endothelium cholesterol concentration was detected to be above 
the average of that sample. Based on the ratio 385/369, the cholesterol in the normal arteries was mainly 
unesterified cholesterol (m/z 385). The ratio 385/369 showed that the proportion of CE was the highest in the 
atheromas and in advanced stage lesions (Study I, Figure 2D). Unesterified cholesterol is found in the plasma 
membranes of all cells (Lange et al., 1989). The difference in the intensities of the different cholesterol 
species, m/z 385 and m/z 369, was substantial between normal intima and a fatty streak: the ratio 385/369 in 
fatty steaks (0.14) was half of the same ratio in the normal intima (0.3). In the atheroma-stage (0.07) and in 
the advanced lesions (0.1) the ratio 385/369 indicated a high concentration of CEs deep in the intima. Ratio 
385/369 was one fourth of the ratio in the normal intima (Study I, Figure 1D). CEs can be a target of 
hydrolysis by LAL in the extracellular space lipoprotein-derived lipid particles (Hakala et al., 2003), thus 
affecting the ratio 385/369. These results show that in the fatty streaks, part of the cholesterol was now in 
esterified form (m/z 369), and as also apoB-100 was found in the same areas, CEs are likely to be derived 
from plasma apoB-100-containing lipoproteins, notably from LDL and possibly from VLDL-remants. In the 
atheroma stage, cholesterol m/z 369 was concentrated near the internal elastic lamina with linoleic acid, oleic 
acid, and palmitic acid, where alsoa dense distribution of vitamin E (m/z 430) was detected. These findings 
also support the presence of plasma lipoprotein-derived lipid particles. Vitamin E can be considered a marker 
of lipoproteins, as it travels as a component of them (Esterbauer et al., 1991) and it was found to co-localize 
with total cholesterol signal both in an atheroma coronary artery and in an artery with an advanced lesion. 
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Red blood cells as a source of unesterified cholesterol 
In the atheroma-stage, no glycophorin A indicating red blood cells or iron deposits were found, while in the 
advanced lesions, glycophorin A-stainings indicated heavy deposits of red blood cells (Study I, Figure 6). 
Hyperplastic intima in the most stenotic arteries contained dense neovascularization (Study I, Figure 6), and 
red blood cells could leak through lesions in the vulnerable neovessels (Sluimer et al., 2009), and be a source 
of unesterified cholesterol in the intima (Virmani et al., 2005). That might explain the higher ratio of m/z 385 
to m/z 369 in the advanced lesion than in the atheroma.  
Phospholipids in the coronary artery sections 
In normal coronary arteries, intima is a thin layer between endothelium and internal elastic lamina and only 
mild adaptive thickening can be noticed (Stary et al., 1992). The most common phospholipids are PC, LPC 
and SM that share a common choline head group (C5H15NPO4+). In the TOF-SIMS-analysis, the 
phospholipids were detected both as molecular ions either on positive ion mode (+) or negative ion mode (-): 
(PC 32:0, PC 34:3, PC 34:2, and PC 34:1; SM 18:1, SM 18:0, SM 16:1, and SM 16:0; LPC 16:0 and LPC 
18:0 (Table 1, Study I), and ceramide. Total choline-phospholipids were detected as m/z 184, which was 
derived from the choline-headgroup. The intensities were normalized to the pixel count of the analyzed area. 
Ratio of phospholipids to cholesterol 
As the intensity of the common choline headgroup m/z 184 was determined by TOF-SIMS, the signal was 
found to be the lower the more advanced stage of atherosclerosis the analyzed areas were (Study I, Figure 
2A). The lowest intensities were found in the advanced-stage lesions. Specific PC intensities were the lowest 
at the atheroma-stage and (Study I, Supplemental Figure 5A), as in the advanced-stage lesions the intensity 
was again 1.5-fold compared to the intensity in the atheroma. In the normal intima and in fatty streaks, the 
ratio of cholesterol to phospholipids (Chol/PL = m/z 385 + m/z 369 / PC + SM) was low (the value of the 
ratio is 1 in the normal intima, 2 in the fatty streak). In the atheroma, however, the ratio (11.1) was 15-fold 
higher than in the normal intima (0.7) due both to decrease in phospholipids and increase of CEs. In the 
advanced-stage artery, the ratio was lower than in atheroma (5.6), but still 8-fold higher than normal intima 
(Study I, Supplemental Figure 5). While the ratio was 2-fold compared to normal intima in the fatty streak-
phase, it was not significantly higher although in the immunohistochemistry apoB-100 was already present. 
As in a normal intima with adaptive intimal thickening the most abundant cell population are smooth muscle 
cells (Nakashima et al., 2002), the dominance of phospholipids is consistent with the result of the 
measurements of Tulenko and co-workers, of smooth muscle cell membrane cholesterol/phospholipid ratio 
(0.96:1) (Tulenko et al., 1998). The Chol/PL-ratio in the coronaries with an advanced lesion was still high, 
but only half of the ratio observed in the atheroma-stage. Decline of total phospholipid ion m/z 184 intensity 
may derive from degradation of either PC or SM or both. Also intensity of SM affects to the Chol/PL-ratio, 
and SM-hydrolyzing SMase has been detected in atherosclerotic lesions (Marathe et al., 1999), and in 
accordance with that, a small increase of ceramide-intensities was detected in atheroma-stage lesions. Smith 
and her co-workers analyzed human aortae and extracted lipid from from whole plaques in different stages of 
atherosclerosis. In the fatty streak –phase the Chol/PL-ratio was 1.8—2.4 and in the atheroma-stage and in 
advanced lesions the ratio Chol/PL was 13.3.—15.5 (Smith, Slater, and Chu, 1968), which is well in 
accordance with the results acquired with TOF-SIMS.  
Ratio of lysophosphatidylcholines to phosphatidylcholines 
The highest intensity of LPC was found in the atheromas (Study I, Supplemental Figure 5 A). Also the ratio 
of LPC to PC (LPC/PC) was found to be different in different types of lesions in Study I. The ratio LPC/PC 
was the highest (0.9) in the atheroma-stage of coronary artery lesions. In the advanced-type lesions the ratio 
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of LPC/PC was lower (0.5) than in the atheroma-stage, but still higher than in the normal intima (0.2) (Study 
I, Figure 5). LPC may be derived from oxidation of PC (Esterbauer et al., 1992) or PC hydrolysis by PLA2. 
Several PLA2-enzymes have been detected in the atherosclerotic arteries, some of which can hydrolyze PCs 
in intact LDL, while some of them use modified LDL as substrate (Öörni and Kovanen, 2009), and also 
oxidation have been shown to lead to PC hydrolysis (Steinbrecher et al., 1984). Smith and co-workers 
extracted lipids from aortic lesions and the ratio LPC/PC was between 0.14—0.4 in fatty streaks and 0.5—
0.9 in the necrotic core of advanced lesions (Smith, Slater, and Chu, 1968). Later LPC was found to be 
capable of in vitro activating macrophages into phagocytocing especially complement-bound targets, in this 
case red blood cells (Ngwenya and Yamamoto, 1985). PC hydrolysis products fatty acids and LPC are 
transported out from the plaque with albumin. LPC is capable in inducing secretion of inflammatory 
cytokines from human monocytes in vitro, and saturated LPC 18:0 and 16:0 had larger effect than 
unsaturated LPCs did (Liu-Wu, Hurt-Camejo, and Wiklund, 1998). 
Fatty acids in the coronary artery sections 
Fatty acids were detected in the negative mode of TOF-SIMS. The detected fatty acids were palmitic acid 
(16:0), stearic acid (18:0), oleic acid (18:1), linoleic acid (18:2), and arachidonic acid (20:4). The fatty acids 
were partly free fatty acids, partly fragmented from CEs, TAGs, PCs, and SMs (Debois et al., 2009). In the 
normal coronary arteries, 16:0 and 18:0 were evenly distributed and found in all artery layers. 18:2 and 18:1 
were found from the fatty streak to the advanced lesion-stage, where they co-localized with cholesterol. In 
LDL, the most abundant fatty acid is 18:2, which is esterified in CEs, and the second most abundant fatty 
acid is 16:0, in the phospholipids of LDL (Esterbauer et al., 1992) Oleic acid is abundant in the foam cells 
since ACAT, the enzyme that esterifies cholesterol into CEs in macrophage cytoplasm thus generating foam 
cells, prefers oleic acid (Brown, Ho, and Goldstein, 1980). 
Triacylglycerols in the coronary artery sections 
In the coronary arteries analyzed with TOF-SIMS, TAGs were detected as diacylglycerols (DAG). The 
molecular ion of TAG was very weak. Sjövall and co-workers showed in a principal component analysis that 
the signals of DAGs and TAGs have a strong positive correlation (Sjövall et al., 2008) and Debois and co-
workers performed TOF-SIMS analysis on TAG species from which the result was strong signal of DAG-
molecular ions (Debois et al., 2009). Based on these data DAGs were considered as a reliable marker of 
TAGs in this type of analysis. The detected DAGs in the Study I were 32:2, 32:1, 32:0, 34:2, 34:1, 36:3, and 
36:2, and they were interpreted as TAGs according to the results of Sjövall and Dubois and their groups. A 
strong intensity of TAGs was found in the coronary samples with normal intima next to the endothelium. 
Interestingly, cholesterol and TAGs did not co-localize. In the advanced lesions, TAGs were located next to 
the endothelium of the coronary arteries at the sites of neovascularization, and also near to the endothelia of 
newly formed microvessels, while cholesterol was located deeper in the intima. This suggests either that the 
TAG-rich lipoproteins did not reach the site of cholesterol accumulation due to degradation of the TAGs in 
the tissue or due to steric hindrances, mainly because of the large size of the TG-rich particles. As the 
endothelium of atherosclerotic lesion sites is known to be eroded, i.e. local losses of endothelial cells 
(Mäyränpää et al., 2007), the larger lipoproteins can have acces from the coronary lumen to the coronary 
intima. The size distribution of particles that can enter the uncompromised endothelium was described by 
Nordestgaard and Zilversmit (Nordestgaard and Zilversmit, 1988): the entering particles are smaller than 75 
nm, while particles larger than that do not cross the endothelium unless it is leaky (McDonald, Thurston, and 
Baluk, 1999). Another origin of TAG in the intima may be the foam cells. In vitro-experiments by Boström 
and co-workers show, that if macrophages are exposed to hypoxia, the lipid droplets of these macrophages 
are enriched with TAGs (Boström et al., 2006). 
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Lipids in the media 
In the sections of media that were next to intima with atheroma-stage or advanced lesion, higher lipid ion 
intensities were detected than in the media sections next to normal intima. Both total cholesterol and vitamin 
E -intensities had significantly higher normalized intensities in the media next to atherosclerotic intima than 
in the media next to normal intima, and this suggests increased infiltration of plasma lipoproteins into the 
mediaIn the areas of media that were next to advanced plaque areas, the media contained more total 
cholesterol, and vitamin E, and also more PCs than in the areas of media that were next to a healthy intimal 
areas (Study I, Supplemental Figure 7). Previously, media lipids have seldom been analyzed in 
atherosclerosis. In 1966, Insull and Bartsch extended their analysis also to the media of thoracic aorta, and 
saw "occasional finely dispersed lipid adjacent to the intimal fatty streak" (Insull and Bartsch, 1966). They 
report that patients with atherosclerotic lesions had slightly higher lipid content in the media compared to 
non-atherosclerotic patients, but the difference was not statistically significanat. However, they found slight 
correlation between medial cholesterol content to the fatty streak cholesterol content (Insull and Bartsch, 
1966). Thus the lipids in the intima seem to affect slightly the lipid composition of the media. This may be 
due to elastolytic fragmentation of internal elastic lamina in the plaque as the macrophages in the intima 
secrete MMPs (Pasterkamp et al., 2000). Smith and Staples found earlier that when internal elastic lamina 
was intact, LDL concentration on the medial side of internal elastic lamina was only 0.3 % of that in the 
intima, and if the internal elastic lamina was damaged, medial concentration of LDL increased significantly 
(Smith and Staples, 1980). Also Sinapius report that large atheromas are associated with medial lipid 
(Sinapius, 1980). Evidence that point to this direction were found also in this study. As atherosclerosis is 
considered as an intimal disease, these findings were interesting, but due to small sample size, more evidence 
is necessary before definitive conclusions can be drawn.  
 
 
 
 
 
 
 
 
 
 
 
 
While the MS-imaging analysis of coronary artery sections shows the total lipid burden of a certain area of 
an artery (Study I), several signs of lipid modifications could be detected. The Chol/PL-ratio, where the ratio 
changes between the atheroma-stage and advanced lesion-stage reflected changes not only in cholesterol 
levels but also in levels of PC and SM, and LPC/PC-ratio, which showed the degree of PC degradation, were 
Figure 18 Spatial 
distribution of lipids in a 
normal, (A), atheroma-stage 
(B), and an advanced-stage 
(C) coronary artery. 
Schematic drawing and a ToF-
SIMS-generated image of 
respective stages of 
atherolsclerosis. cholesterol 
and triglycerides co-localize 
only minimally in the 
atherosclerotic intima. 
Cholsterol = red, 
Triacylglycerols = green, 
phospholipids = blue. 
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both significantly different in the atheroma-stage plaques of a coronary arteries compared to a normal 
coronary artery intima.  
Previously, no detailed analysis of spatial lipid composition of the human coronary arteries has been 
performed. In this study, TOF-SIMS analysis of the coronary arteries revealed that the lipids form distinctive 
domains in the artery during atherogenesis (Figure 18) and extend even to the media. Cholesterol species, 
especially esterified cholesterol, were accumulated deep in the intima, close to internal elastic lamina. The 
cholesterol seems to be derived from lipoproteins in the early lesions while in the advanced lesions, the 
cholesterol seemed to be derived from both lipoproteins and red blood cells, TAGs seemed to accumulate 
separately from cholesterol and were found periendothelially both near the neovessels and the arterial lumen. 
Possible sources of TAGs are chylomicron remnants, VLDL and IDL-particles. In the analysis of spatial 
distribution of lipids in different stages of atherosclerosis, it was also possible to see detailed spatial 
information of the native and modified lipids in the intima. 
Particle modifications in arterial intima and in aortic valve (II and III)  
With imaging MS it was possible to show microscopic and detailed information of spatial distribution and 
the composition of the lipids that had accumulated in the arterial intima at different stages of atherosclerosis 
(Figure 18). However, TOF-SIMS signal contained all lipids acquired from the tissue section surface, both 
from the cell membranes and the extracellular lipid particles. Thus distinguishing the source of the lipids, 
that is, whether the lipids originated from plasma lipoproteins, or if they were derived from dead foam cells 
and were of intracellular origin, was not possible with TOF-SIMS. Also, In study I, comparison of 
immunohistochemistry and TOF-SIMS showed, that esterified cholesterol and apoB-100 were found in the 
same areas of the atherosclerotic plaques. These results gave a rationale for isolating the extracellular lipid 
particles and further analyzing the particles from sites prone to atherosclerosis in Studies II and III.  
The extracellular lipid particles were isolated from human aortic valve leaflets (Study II) and human carotid 
arteries (Study III). The isolated lipid particles were analyzed for their lipid composition, oxidation status, 
and size. The particles isolated from aortic valve leaflets and carotid arteries resembled the particles found in 
works by Guyton and co-workers (Guyton and Klemp, 1994), Hoff and co-workers (Hoff and Gaubatz, 
1982; Hoff and Morton, 1985), and Chao and co-workers (Chao et al., 1988; Chao et al., 1990). Lipid 
analysis by thin layer chromatography and mass spectrometry showed that the lipid contents of the particles 
were different from plasma LDL and VLDL, and the particles in the stenotic aortic valves showed different 
lipid composition from the particles isolated from the coronary artery plaques. The proportion of PC was 
decreased both in the particles isolated from aortic valves and in the particles isolated from carotid arteries, 
and the proportion of free fatty acids was increased in the particles isolated from either tissue when 
compared to the plasma LDL lipid composition. The lipid particles showed signs of modifications by 
oxidation and diverse lipolytic and proteolytic enzymes. The physical and chemical characteristics of the 
extracellular lipid particles will be discussed in more detail in the following chapters. 
Sizes and rate zonal floating of the extracellular lipid particles  
The extracellular lipid particles isolated from stenotic aortic valves (Study II) and carotid artery lesions 
(Study III) had common properties. Particles isolated from both sources were larger than plasma 
lipoproteins, but mainly smaller than the intracellular lipid droplets, the size of which can be even several 
micrometers (Figure 19). Dynamic light scattering shows that the extracellular lipid particles in aortic valves 
(Study II) had an average diameter of 400 nm (range 30—1000 nm) and the average diameter of the particles 
isolated from carotid arteries was 500 nm (range 40—1000 nm). The size-range of the experimental 
intracellular lipid particles (Study II) overlapped the size-range of the particles isolated from carotid arteries 
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(Figure 19; Study III, Figure 3). Dynamic light scattering does not separate large spherical particles from 
large particle aggregates. Thus part of the largest particles may also be aggregates formed of several smaller 
particles or particles in process of fusing together. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
When the aortic valve and carotid artery plaque extracellular lipid particles were separated by rate zonal 
ultracentrifugation, four distinct size-peaks in the flotation profiles were observed (Figure 20, blue line). 
After measuring the peak fractions with dynamic light scattering, the groups were termed according the sizes 
of the particles XL, L, M, and S, where the S-sized particles were close to the size of LDL and XL-sized 
particles were close to the size of experimental intracellular lipid droplets (Figure 19; Study II, Figure 3). 
The particles that were isolated from the healthy aortic valves (Figure 20, green line) floated very close to the 
LDL particles (Figure 20, black line). The extracellular lipid particles isolated from the carotid artery 
plaques, however, were distributed troughout the layers, as the particle size variation was large. Most of the 
apoB-100, as measured by ELISA, was found in the smallest particles that were of the same size as LDL 
both in the aortic valves and in carotid artery plaques (Figure 21; Study II, Figure 3B-C, Study III, Figure 
3B).  
Figure 19. Sizes of the plasma lipoproteins and 
the extracellular lipid particles. The sizes of 
plasma lipoproteins (top panel) and extracellular 
lipid particles from aortic valves and carotid artery 
plaques (lower panel, blue and red, respectively) 
were measured with dynamic light scattering. The 
extracellular particles were in average larger than 
plasma lipoproteins. Also experimental intracellular 
lipid droplets were analyzed (lower panel, in purple). 
Figure 20. Rate zonal analysis profiles of 
extracellular lipid particles,experimental lipid 
ddroplets, and LDL. Several rate zonal 
ultracentrifugation analysis were combined in the 
figure: experimental intracellular lipid droplets 
(orange), extracellular particles isolated from 
healthy aortic valve (green), stenotic aortic valve 
(blue), and carotid artery plaques (red), and 
plasma LDL (black line). The experimental 
intracellular lipid droplets floated in a top layer 
of the tube, while LDL-particles floated near the 
bottom ot the tube. The extracellular lipid 
particles from healthy aortic valves floated quite 
similarly to the LDL-particles. The extracellular 
particles from stenotic aortic valves and from the 
carotid artery plaques are distributed throughout 
the layers. 
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With rate zonal ultracentrifugation analysis, it could be seen that the size of the particles were very different 
from those of the plasma lipoproteins, but they also differed from the intracellular lipid droplets. Enzymatic 
modifications change the way how the lipid particles float in the ultracentrifugation. Pentikäinen and co-
workers modified native LDL with several different methods (e.g. by proteolysis, Cu2+-oxidation, SMase-
lipolysis, and glycosylation), and the particles that had been proteolyzed, Cu2+-oxidized, bound to LDL-
antibody complexes, or lipolyzed, were found to float throughout the layers of rate zonal analysis 
(Pentikäinen, Lehtonen, and Kovanen, 1996). In Studies II and III, the rate zonal analysis profiles of the 
extracellular lipid particles were similar to those in Pentikäinen's work, which suggested that high degree of 
modification of the plasma lipoproteins from which the particles were derived had occurred in the tissues. 
 
 
 
 
 
 
 
 
 
 
Lipid analyses 
As the lipid particles isolated from the carotid arteries were isolated from pools consisting of several carotid 
artery samples derived from several different patients, and the particles were not fractioned by size, each 
value obtained represented an average of all particles in the particular pool (Study III). In contrast to that, the 
particles from aortic valves derived from individual samples (one valve leaflet at a time). The particles 
isolated from a single valve leaflets were fractionated by size, and this enabled studies yielding information 
from individual patients (Study II). The possibility to collect data from an individual stenotic valve leaflet, 
rather than from a pool of several atherosclerotic carotic arteries, revealed large variation in the lipid particle 
lipid compositions not only between the the different sized particles but also between individuals (Figure 22) 
In the samples derived from some patients the small particles resembled LDL in size and lipid composition, 
whereas in other samples the particles were more VLDL-like with large amounts of TAGs and with lower 
amounts of CEs. In the pools of carotid extracellular particles, which represented averages of all patients in 
the particular isolation pool, the lipid composition of the particles had features from LDL rather than from 
VLDL, as the proportion of CEs was much higher than the proportion of TAGs. Next, these modifications in 
lipid compositions will be discussed. 
 
 
 
Figure 21. Cholesterol and apoB-100 in the carotic 
artery extracellular particles analyzed with rate 
zonal ultracentrifugation. Fractions collected from 
ultracentrifugation tube were analyzed by ELISA-for 
apoB-100-content and fluorometric Amplex Red 
analysis for cholesterol content. The analyses of the 
particles showed that while cholesterol was found in 
all fractions, intact apoB-100 was found mainly in the 
particles that floated in same layer as native LDL. 
Figure shows average results of two samples. 
Particles that floated on the surface of the tube were 
larger than the particles that were collected from the 
bottom fractions of the tube. 
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Phospholipids and effects of phospholipolysis in the extracellular lipid particles 
Phospholipids constitute the primary portion of the surface monolayer of the lipoproteins and the bilayer of 
the cell plasma membranes. The most abundant phospholipid in LDL is PC, which comprises 14 % of total 
lipids. Of LDL phospholipids, 64 % is PC followed by SM and LPC, with 26 % and 11 % contributions, 
respectively (Esterbauer et al., 1992). Phospholipolysis of these lipids can produce ceramides, DAGs, 
lysophospholipids, and free fatty acids, which are also found in LDL particles in minute amounts. LDL 
particles also contain small amounts of PE, PS, and PI.  
Phosphatidylcholine and lysophosphatidylcholines 
In LDL, the main phospholipid is PC (Figure 23), of which the most abundant PC is PC 34:2, with fatty acyl 
chains 16:0 and 18:2. The extracellular particles isolated from stenotic aortic valves and carotid arteries 
shared common features: In aortic valve extracellular particles and in the carotid plaque extracellular 
particles, the most common PC was PC34:1 (16:0/18:1) (Study III, Supplemental Figure IV). Interestingly, 
the aortic valve and the carotid artery extracellular lipid particles both were found to contain several PC-
species that may contain arachidonic acid in their sn2-position, such as PCs 36:4 (16:0/20:4), 36:5 
(16:1/20:4), 38:4 (18:0/20:4), and 38:5 (18:1/20:4), and the proportions of 36:4 and 38:4 were almost 9 mol-
% of the total PC. Arachidonic acid of membrane PCs is an upstream molecule in the cyclo-oxygenase and 
leukotriene pathways, and, as such it is a source of prostaglandins and thromboxanes, and leukotrienes, 
respectively (Samuelsson, 1991). Thus, arachidonic acid can be considered a potentially proinflammatory 
molecule (Calder, 2006). In feeding experiments of piglets, dietary arachidonic acid has been found to 
Figure 22. Lipid contents of the 
extracellular lipid particles. 
Lipid contents were analyzed 
from extracellular particles 
isolated from stenotic aortic valve 
leaflets (A, C, and D), and carotid 
artery plaques (B). In the pie 
charts, several pieces of aortic 
valve or carotid artery were 
combined for analysis (A, B). In 
the columns (C, D), each column 
represents lipid particles isolated 
from an individual patient. Lipid 
analysis was performed from 
particles that were sorted by their 
size. LPC = 
lysophosphatidylcholines, PC = 
phosphatidylcholine, SM = 
sphingomyelin, UC = unesterified 
cholesterol, TAG = 
triacylglycerol, CE = cholesteryl 
ester Columns A-G denote 
different patients. 
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become incorporated into LDL phospholipids, when the arachidonic acid in their feed was introduced in 
TAGs (Amate, Gil, and Ramirez, 2001). 
 
 
 
 
 
 
 
 
The total proportion of PC in lipid particles isolated from either aortic valves or carotid arteries was lower 
than it was in LDL The lipid contents of all extracellular lipid particles were different from both LDL and 
VLDL. PC/SM-ratio in the particles was lower than in LDL, due to the lower of PC-content of the particles. 
A large variation in aortic valve lipid profiles between individual patients was found. The proportion of PC 
in small aortic valve lipid particles varied from 40 % (patient B, Figure 22) to 0 % (patient G) The low 
PC/SM-ratio likely indicates the loss of PC, and apart from oxidation that will be introduced later, a possible 
source for the LPC and free fatty acids could be hydrolysis of PC with PLA2-enzymes. PLA2-enzymes are 
phospholipases that are able to hydrolyze the ester bond between a sn2-carbon of a glycerol backbone and an 
acyl chain in a phospholipid. More than thirty PLA2-enzymes have been already described (Murakami et al., 
2015), and 10 of them are recognized in the atherosclerotic intima (Öörni and Kovanen, 2009). PLA2-IIa that 
uses oxidized LDL as its substrate, has been found in the valve tissue (Kupreishvili et al., 2011), and high 
concentrations of Lp-PLA2 are found in plasma of patients with severe aortic stenosis (Kolasa-Trela Renata, 
2012), and in Study III, PLA2-V was seen in the carotid artery lesion in the immunohistochemistry, albeit in 
modest intensity (Figure 24). Lp-PLA2 has also been associated with carotid artery atherosclerosis 
(Goncalves et al., 2012; Mannheim et al., 2008), and its highest expression is found in the necrotic core of a 
plaque. Hydrolysis of PC is a prominent phenomenon occurring in the extracellular lipid pool and can affect 
the aggregation of the lipid particles and hence the uptake by macrophages (Griffin et al., 2005). Also fusion 
of LDL-particles by the action of PLA2-hydrolysis has been shown (Hakala et al., 2001). The physical 
properties of isolated particles in Studies II and III point to the direction that PLA2-hydrolysisis is partly 
responsible of such modifications.  
In coronary arteries in Study I, LPC was found to be enriched in atheroma and in complicated lesions. 
However, in the extracellular lipid particles that were isolated from aortic valves (Study II) or carotid arteries 
(Study III), the proportion of LPC (0.8 %) in atherosclerotic carotid artery lesions was, surprisingly, not 
found more pronounced than in plasma LDL (2.7 % (Esterbauer et al., 1992)), although the proportion of PC 
was less than half (6.4 %) of that in plasma LDL (14.5 %, (Esterbauer et al., 1992)). Also, somewhat 
surprisingly, the proportion of LPC in the aortic valve leaflets (2.8 %) was not significantly higher than in 
LDL (Figure 22 A-B). These low levels of LPC were found in pools of several carotid artery plaques or 
aortic valves. The seemingly low levels or even apparent loss of LPC was hypothesized to be derived from 
the analysis method. An averaging effect was a result of an act of pooling the lipid particles that had been 
isolated from several valve leaflets or pieces of carotid artery plaques. As Figure 22 panels C and D showed, 
particles isolated from individual patients had very different proportions of LPC in the lipid compositions. 
Figure 23. Lipid compositions of 
plasma lipoproteins LDL, IDL, and 
VLDL. LDL, IDL, and VLDL lipid 
compositions were analyzed by TLC. 
© Lehti et al (Lehti, 2013) 
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The lipid particle from several patients contained little or no LPC while the particles from some patients 
were rich in LPC. When the individual samples were combined as a pool, the extrema values were not 
detected. Another possible reason for low LPC-levels in the extracellular particles could be albumin, which 
can transport not only fatty acids but also LPC (Switzer and Eder, 1965). When the valve leaflets were 
viewed individually (patients A-G in Figure22), and the lipid particles were separated by their sizes from 
each valve leaflet, the proportion of LPC was found to vary between individuals (Study II, Figure 7A). LPC 
was found especially in the small lipid particles that closely resembled LDL in size and also in the medium-
sized particles that were close to VLDL in their size. In some aortic valve samples, PC seemed to be non-
hydrolyzed, and PC/SM-ratio resembled that of LDL, while in some samples, PC/SM-ratio was lower than in 
LDL and VLDL, where the ratios were found to be 2.9 and 3.3, respectively (Study II), consistent with 
Esterbauer and co-workers (Esterbauer et al., 1992). In the small aortic valve lipid particles, the ratio varied 
between 2.2 and 0.2 (Study II), and in the carotid arteries combined, the ratio was 0.5 (Study III). In the 
whole tissue extracts by Smith and co-workers PC/SM-ratio was 1.05 in the fatty streaks and in the necrotic 
core it was 0.11, as large amount of PC seemed to have been degraded (Smith, Slater, and Chu, 1968), 
however, there the proportion of LPC was again surprisingly low. Chao and co-workers (Chao et al., 1990) 
isolated lipid particles from human atherosclerotic abdominal aortae. They classified the particles as 
"esterified cholesterol-rich lipid particles" (d < 1.01 g/ml) and "unesterified cholesterol-rich lipid particles (d 
= 1.03—1.05 g/ml), The unesterified cholesterol-rich lipid particles were multilamellar vesicles (Chao et al., 
1990). The PC/SM ratios were 0.6 and 0.5, respectively, similar to the carotid extracellular lipid particles in 
Study III.  
 
 
 
 
 
 
 
 
Sphingomyelin and ceramide 
SM is the second-most abundant phospholipid in LDL and also in the extracellular lipid particles that were 
isolated from aortic valves and carotid artery lesions. SM can get hydrolysed by (acid) SMase to produce 
ceramide and a phosphocholine. As SMase is detected in the arterial intima (Marathe et al., 1999; Marathe et 
al., 1998) (and it was also detected in the carotid artery intima in this thesis (Figure 24), ceramides were 
expected to be detected in the lipid particles that were isolated from atherosclerotic carotid artery lesions. 
Unexpectedly, no ceramide was found in the isolated extracellular particles, while in the Study I, ceramides 
were detected in the atheroma-stage coronary artery sections in low intensities. Also the extracellular 
particles isolated from the aortic valve leaflets were devoid of ceramides. In the coronary atheromas, 
ceramides were found to have a slightly higher intensity compared to a normal intima; however, the 
intensities of SMs were ten-fold compared to the intensities of ceramides (Study I). Schissel and co-workers 
(Schissel et al., 1998; Schissel et al., 1996) isolated extracellular lipid particles from human atherosclerotic 
plaques from aortic aneurysms, and found that aggregated lipid particles were enriched in ceramide, while 
Figure 24. Sphingomyelinase 
(SMase) and phospholipase A2-V 
(PLA2-V) in carotid artery intima. 
Immunohistochemical analysis of 
SMase and PLA2 in a carotid artery 
intima. SMase and PLA2 are secreted 
by the endothelial cells and intimal 
macrophages in the atherosclerotic 
intima.  
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the unaggregated particles were not. In the aggregated particles they found 10-50-fold increase of ceramide 
compared to plasma LDL. The differences between the present results and those obtained by Schissel and co-
workers may be rooted to the different methods of isolation of the lipid particles and the detection method 
used in our study. They isolated the aortic lipid particles using an affinity immunoabsorption column with a 
polyclonal apoB-100-antibody, which excluded all but apoB-containing particles (Rapp et al., 1994). In their 
papers, Schissel and co-workers used DAG kinase using [y-32P]ATP to phosphorylate ceramide and DAG 
(Schneider and Kennedy, 1976) from the samples in purpose to analyze the amount of ceramide in the 
samples. In the current works (Study II and III), the extracellular lipid particles were not fractionated 
according their protein content, and mass spectrometry was used to analyze ceramide from the particles. 
Ceramide has two hydrophobic acyl tails and a neutral head group, and has thus a limited ability to become 
ionized. As the mass spectra were recorded from a mixture of lipids, the competition of ionization favoured 
the phospholipids that were more easily ionized, i.e. PCs and SMs. Thus mass spectrometry is likely to 
record ceramide well only if the proportion of it in the lipid mixture is extremely high or if ceramides are 
isolated from the total lipid mixture and measure separately.  
Cholesterol and neutral lipids in the extracellular lipid particles  
CEs are the most abundant neutral lipids in the core of LDL-particles, whereas TAGs are the most abundant 
neutral lipids in the the core of VLDL. The lipoprotein core can be hydrolyzed in macrophages by LAL that 
hydrolyzes the ester bond of CE to produce unesterified cholesterol and free fatty acids and TAGs into 
glycerol and free fatty acids. LAL can also be found pericellularly and has been shown extracellulary in 
human atherosclerotic arterial intima (Hakala et al., 2003). 
Cholesterol and cholesteryl esters 
Imaging MS of the coronaries showed that cholesterol distribution in plaques of different stages of 
atherosclerosis followed the distributions of apoB-100 and vitamin E (Study I). As vitamin E is carried in 
lipoproteins (Esterbauer et al., 1991) it suggested that the cholesterol in the coronary arteries was at least 
partly derived from plasma lipoproteins (Study I). Extracellular lipid particles isolated from both the aortic 
valves (Study II) and from the carotid arteries (Study III) contained large amounts of unesterified cholesterol 
(Figure 22). CE is the most abundant lipid species in LDL, and also in the extracellular lipid particles of 
carotid arteries and in the total lipid pool of aortic valve leaflets. In the lipid particles isolated from aortic 
valve leaflets and which had been fractionated according to their size, CEs were most often found in the 
particles that contained the highest concentration of apoB-100 as analyzed by ELISA (Study II). Unesterified 
cholesterol was found in the larger particles that also contained much less antibody-recognized apoB-100 
and/or apoE. CEs of the intimal extracellular lipid particles contain the same type of fatty acids as do plasma 
lipoproteins, but in very different proportions. Cholesteryl linoleate (CE 18:2) is the most abundant CE in 
LDL and it was also most abundant in the extracellular lipid particles both from the aortic valve leaflets and 
from carotid artery lesions. Interestingly, in the aortic valve lipid particles CE 18:3 was the second most 
abundant CE, although in LDL and in the carotid lesion lipid particles the second most abundant CE was 
cholesteryl oleate (CE 18:1). The third most abundant CE in the carotid extracellular lipid particles was CE 
18:3 that contained either the essential fatty acid α-linolenic acid, (ALA;18:3(n-3)) or gamma-linolenic acid 
(GLA; 18:3(n-6)). ALA is derived only from diet but GLA can be produced endogenously from linoleic acid 
18:2. Mass spectrometry used in this analysis cannot distinguish between the two species, as it only detects 
the mass-charge relationship of the molecules. 
The extracellular lipid particles isolated from the carotid arteries in Study III contained particles that were 
the same size as the experimental intracellular lipid particles (Figure 19, purple line). As mentioned above, 
the most abundant CE in LDLis CE 18:2 (Liu, Bagdade, and Subbaiah, 1995). In the foam cells, however, 
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CE 18:1 is the most abundant CE. In the cells, the LDL CEs are hydrolyzed in the lysosomes into 
unesterified cholesterol and an acyl chain, and the unesterified cholesterol is re-esterified by aceyl 
coA:cholesteryl acyltransferase / Sterol O-acyltransferase 1 (ACAT/SOAT1) to be stored in foam cell lipid 
droplets (Brown, Ho, and Goldstein, 1980). ACAT/SOAT1 prefers oleic acid as a substrate over linoleic 
acid, and thus the main CE in the intracellular lipid droplets is cholesteryl oleate. The ratio of cholesteryl 
oleate to the sum of cholesteryl oleate and cholesteryl linoleate (18:1/(18:1+18:2)) in the carotid artery lipid 
particles in Study III was 0.35, and in LDL it was 0.18. In stenotic aortic valves of Study II the ratio was 
0.19. According to Guyton and Klemp (Guyton and Klemp, 1994), this ratio in the extracellular lipid 
particles is between 0.2 and 0.47, while in intracellular lipid droplets it could be as high as 0.8. That suggests 
that the extracellular lipid pool was mostly of lipoprotein origin, but that it may also contain small amounts 
of intracellular lipid droplets derived from apoptotic foam cells that had released their lipid droplet contents 
into the extracellular compartment. In Study I linoleic, oleic and palmitic acids were found to co-localize 
with cholesterol m/z 369 in the coronary artery sections, mainly in the atheroma- and advanced plaque -
stages of atherosclerosis, in the TOF-SIMS-generated images (Study I, Figure 3), and thus be CE-derived. 
An interesting group of CEs in the carotid extracellular lipid particles were the CEs with odd number of 
carbon acyl chains, CE 19:2, 19:1, 17:0, 17:1, and 15:0. The combined proportion of these species was low 
in LDL, 2.6 % of measured CEs, but in extracellular lipid particles the proportion was higher, 11.3 %. In the 
carotid particles CE 15:0 was found to have higher proportion than CE 17:0. Synthesis of 15- and 17-carbon 
chains has been described already in the 1960's in rat adipose tissue (Horning et al., 1961). Contemporarily, 
they have been found to be synthesized also in human tissues: red blood cells, human breast milk, and 
adipose tissue contain saturated odd-chain fatty acids, and fatty acid 17:0 generally dominates over fatty acid 
15:0, as reviewed by Jenkins and co-workers (Jenkins, West, and Koulman, 2015). Another source of these 
lipids can be cow's milk (Baumann et al., 2016; German and Dillard, 2006), and the odd number carbon acyl 
chains can also be derived from bovine meat, mutton, and pork (Mitchaothai et al., 2007), but can also be 
derived from plant sources. In dairy fat, the fatty acid 15:0 is the dominant one over fatty acid 17:0 (Jenkins, 
West, and Koulman, 2015). That suggests that the fatty acyl moiety of thee odd-chain CEs in the 
extracellular lipid particles would be at least partly derived from a dietary source. The β-oxidation product of 
these fatty acids, propionyl-CoA, can be utilized as a substrate in the citric acid cycle in all cells, and the 
odd-chain fatty acids are thus catabolized efficiently. Also, the intracellular enzyme LAL can use CE of 
various chain lengths as a substrate (Sheriff, Du, and Grabowski, 1995). Thus the reason for their 
accumulation is not clear.  
Triacylgylcerols and free fatty acids 
TAGs are the main lipid species of VLDL and there are still minor amounts of them in the plasma LDL 
(Figure 23). In the extracellular lipid particles of aortic valve leaflets (Study II) and in the carotid arteries 
(Study III), the proportion of TAGs was very similar. Similarly with the phospholipids or CEs also the TAG-
content of the extracellular lipid particles isolated from extracellular lipid particles from aortic valves had a 
high individual variability between patients. Some patients had LDL-like TAG-content in the stenotic aortic 
valve particles, while the particles isolated from other patienst resembled more VLDL by their lipid 
composition (Figure 23).  
LPL is found on the luminal side of capillary endothelium, and it is possible that the TAG-rich particles are 
stripped from the TAG load before they even enter the intima (Pentikäinen et al., 2002). Small VLDL-
remnants can have an access into the intima (Nordestgaard and Zilversmit, 1988), and TAG-rich particles 
have an access into the intima through a damaged endothelium (Frank and Fogelman, 1989). Free fatty acids 
are used as energy source for the cells in the arterial wall and for the heart muscle, and they are produced 
from TAGs by LPL on the endothelial cells for that purpose. LPL mRNA is expressed by macrophages, but 
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only in modest quantities (Mattsson et al., 1993). Phospholipids are also a source of free fatty acids, and 
especially arachidonic acid is carried in phospholipids to be used as a material for prostaglandin and 
leukotriene synthesis. The isolated extracellular particles from the aortic valves and the carotid arteries 
contained free fatty acids in quantities that are not found in circulating plasma lipoproteins (Study II and III). 
Lähdesmäki and co-workers have presented data showing that acidic pH tends to prevent the products of 
lipolysis from leaving the LDL-particles (Lähdesmäki et al., 2009). Here, the free fatty acids source was 
likely the PC, the proportion of which was dramatically decreased when compared to plasma lipoproteins. 
Also the CEs may have been a source of free fatty acids, as LAL, that has been shown to exist also 
pericellularly (Hakala et al., 2003), cleaves the fatty acids from the lipoprotein core producing unesterified 
cholesterol and free fatty acids. Free fatty acids can be pro-inflammatory (Dasu and Jialal, 2011; Joosten et 
al., 2010), and the free fatty acids are also considered cytotoxic when their production exeeds their demand 
(Jaishy and Abel, 2016; Schaffer, 2003).  
Oxidation in the extracellular lipid particles 
Malondialdehyde (MDA) and malondialdehyde-acetaldehyde (MAA) adducts are products of lipid 
peroxidation found in phospholipids and lysine residues of proteins, and thus also epitopes in oxidized LDL 
are found in atherosclerotic lesions (Hill et al., 1998; Rosenfeld et al., 1990). Both the aortic valve 
extracellular particles and carotid artery extracellular particles were analyzed the same way for signs of 
oxidation: the apoB-100 lipoprotein-containing particles were tested for their antigenicity against MDA and 
MAA. For the analysis, four antibodies generated against MDA-LDL and MAA-LDL epitopes (Turunen et 
al., 2012; Veneskoski et al., 2011) were used. The probed antibodies revealed the presence of oxidized 
epitopes in the extracellular lipid particle isolate both from the aortic valves (Study II) and from carotid 
arteries (Study III). In plasma LDL samples that were probed alongside with the samples of either aortic 
valve lipid particles or carotid artery lipid particles contained only minimal amounts the epitopes. The 
extracellular lipid particles were isolated in the presence of EDTA, which is suggested to prevent the ex vivo 
–oxidation (Steinbrecher et al., 1984), and thus the detected markers of oxidation had already been present 
before the isolation process. 
The extracellular lipid particles isolated from human aortic valve leaflets (Study II) and human carotid 
arteries (Study III) showed signs of modifications that suggest also possibility of oxidation of the lipid 
particles, such as high concentrations of LPC and high amounts of unesterified (= free) fatty acids. These 
features (increase of free fatty acids and change of density) can be results of phospholipase hydrolysis, but is 
also similar to the results observed by Steinbrecher and co-workers after oxidation of LDL (Steinbrecher et 
al., 1984). Smoking is an exogenous factor that can oxidize LDL and thus affect atherosclerosis and aortic 
stenosis (Syväranta et al., 2014; Yamaguchi et al., 2001).  
Cholesterol crystals  
Previously, Guarino (Guarino, Tulenko, and Wrenn, 2004) showed, that by first hydrolyzing LDL with 
CEase and then subjecting the lipolyzed LDL to hydrolysis by SMase, cholesterol crystals appeared in the 
solution. Based on this background knowledge, in Study III a different approach was used by following the 
works of Chao (Chao et al., 1992) and Plihtari (Plihtari et al., 2010). Thus, the surface of the LDL was first 
destabilized by oxidation, lipolysis, or proteolysis, and thereafter the core CEs were hydrolyzed with LAL. 
After such double-modification, cholesterol crystals were found to be generated in vitro from LDL and 
VLDL (Figure 25; Study III, Supplemental Figure I). When the lipoprotein particles were pretreated with 
lipolysis, proteolysis, or oxidation to destabilize the surface monolayer of the lipoproteins, cholesteryl 
esterase was able to get in contact with CEs and hydrolyze them. This produced unesterified cholesterol, 
which is the prerequisite of cholesterol crystal formation. Such crystals were seen in ToF-SIMS-generated 
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images (Figure 26; Study I, Figure 7). Cholesterol crystals were also seen in TEM electron microscopy 
(Figure 27; Study III, Figure 1) and 3D-electron microscopy images of atheroma in carotid arteries (Figure 
28; Study III, Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. An in vitro-generated 
cholesterol crystal. LDL was 
hydrolyzed with SMase and LAL 
and incubated in +37 °C for 48 h. 
Formed crystals were imaged under 
polarized light. 
Figure 26. TOF-SIMS-generated 
image of cholesterol crystals in a 
human coronary artery intima. 
Cholesterol crystals are depicted in 
green. The phospholipids in intima are 
depicted in red. Each side of the image 
is 101 μm.  
Figure 27. A transmission electron 
micrograph of human 
atherosclerotic carotid artery 
plaque. Atherosclerotic carotic artery 
plaques contained extracellular 
cholesterol crystals, multilamellar 
bodies and extracellular lipid 
particles.  
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In electron microscopic images of carotid atherosclerotic lesions, cholesterol crystals were found to be 
associated with extracellular lipid droplets (Figure 28; Study III, Figure 1), suggesting that the lipid particles 
indeed may grow from the lipid droplets. In the Figure 28 cholesterol crystals having different shapes can be 
seen: part of the crystals are needle-like and part of them are sheet-like, suggesting that the observed 
cholesterol crystals were in different phases of development. Cholesterol crystals are nucleated when a 
sufficient concentration is achieved, in other words, when the concentration exeeds the limit of solubility. 
The critical concentration of cholesterol both in vitro and in an atherosclerotic plaque is approximately 30 % 
of total lipid, which includes cholesterol, CE, and phospholipid (31.5 %, 47.2 %, and 15.3 %, 
respectively)(Katz, Shipley, and Small, 1976). Cholesterol crystal nucleation has been studied extensively in 
the context of bile, and in these studies a cholesterol crystal-growing process was described by Konikoff and 
co-workers (Konikoff et al., 1992). According to their studies, cholesterol crystals are needle-like in the early 
stage and only in the late stage, the crystals become sheet-like.  
Unesterified cholesterol can be detected in atherosclerotic plaques with filipin stainings (Kruth, 1984), and 
also cholesterol crystals are found in the same areas in the arteries, and also in bioprosthetic aortic valves 
(Bocan, Schifani, and Guyton, 1986; Price et al., 2007). Murine models show that unesterified cholesterol is 
found in foam cells that have taken up unesterified cholesterol as re-esterification has decreased (Maor and 
Aviram, 1994) and that crystals form inside the lipid droplets (Kellner-Weibel et al., 1999) and lysosomes 
(Tangirala et al., 1994). Unesterified cholesterol can also be formed in tissues extracellularly from 
lipoproteins by lipolytic activity of LAL that is secreted by macrophages (Hakala et al., 2003) residing in the 
atherosclerotic plaque to the pericellular space. Cholesterol crystals also form inside macrophages (Klinkner 
et al., 1995; Pasquinelli et al., 1989; Tangirala et al., 1994), where LAL is active in the lysosomes and 
intralysosomal concentration of unesterified cholesterol can exeed the required 30 %.  
 
 
 
 
 
 
 
 
 
 
The cholesterol crystals imaged in a carotid artery intima with three-dimensional EM had reached the size of 
foam cells and as they formed large sheets in the tissue, they could even act as barriers to create distinct 
compartments (Figure 28). For the three-dimensional EM images, a sample of a carotid artery lesion was 
imaged with a serial block face-SEM, and the images, 40 nm apart, were stacked using a software. The 
Figure 28. Three-dimensional EM of 
a carotid artery intima. Left 
cholesterol crystals and extracellular 
lipid droplets from which the crystals 
seem to grow out (yellow structures). 
On the right two foam cells, one of 
which surrounds a large cholesterol 
crystal. Blue structures are foam cell 
nuclei. Foam cells are filled with lipid 
droplets (maroon). 
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objects were semi-automatically selected from each layer, again combined with a software (Belevich et al., 
2016), and given pseudo colors to bring out outlines of cells, crystals, and lipid droplets. Macrophages avidly 
phagocytoce cholesterol crystals (Rajamäki et al., 2010), and in the three-dimensional EM image, a 
macrophage was seen surrounding a large cholesterol crystal (Figure 28). Phagocytoced cholesterol crystals 
have been shown to activate the inflammasome both in mice and in human monocyte-derived macrophages 
(Duewell et al., 2010; Rajamäki et al., 2010).  
Small extracellular lipid particles were also three-dimensionally imaged by electron tomography (ET) (Study 
III, Figure 1E and 1F) For ET, a 250-nm-section 250 nm section was imaged from 1 degree intervals. From 
the generated images, objects were manually traced and combined with a software. In the image, 
extracellular lipid droplets were seen to be aggregated and in a process of fusion in the intima. Lipoprotein-
derived lipid particles in the arterial intima will aggregate and fuse after modifications combining oxidation, 
lipolysis and proteolysis as shown by in vitro experiments by Pentikäinen and co-workers and Öörni and co-
workers reviewed (Pentikäinen, Lehtonen, and Kovanen, 1996; Öörni et al., 2000). Previously, fusing 
lipoprotein particles have been seen in experimental set-ups, such as in experiment of Nievelstein and co-
workers, who injected LDL into rabbit circulation and after two hours the lipoprotein particles were seen 
aggregated and some particles seemed to be in the process of fusing (Nievelstein et al., 1991). In those 
images, however, the fusing of lipid particle membranes could not be specifically detected, as it is possible in 
the ET. 
Protein composition of the extracellular lipid particles 
 
 
 
 
 
 
 
 
 
 
 
 
 
Traditionally, it has been suggested that the lipid pool of the arterial atherosclerotic lesions is composed 
particularly of lipid droplets that have been derived from dead foam cells. This may be accurate in the case 
of very advanced atherosclerotic lesions. Here, the protein compositions of the extracellular lipid particles 
were analyzed with ELISA-methods (Figure 29, Figure 30 A), Western blot and protein mass spectrometry
Figure 29. ApoB-100 and apoE-concentrations of aortic valve and carotid artery extracellular lipid 
particles. ApoB-100 and apoE-concentrations were measured with ELISA. ApoE-concentrations are 
measured from the same stenotic valve leaflets as the apoB-100-concentrations.  
67 
 
(Study III, Supplemental Figure III, Supplemental Table 1). The main protein in the extracellular lipid 
particles both in the aortic valves and in carotic arteries was found to be apoB-100 (Figure 29, Figure 30A). 
ApoB-48, the main protein component of the chylomicrons, is an intestinal splice variant from apoB-100, 
and comprises of 48 % of N-terminal amino acid sequence of apoB-100 (Chen et al., 1987), and hence, with 
the mass spectrometry, in which the proteins fragment extensively due to the trypsin treatment, apoB-48 is 
recognized only as a peptide or fragment of apoB-100. A pool that contained carotid artery extracellular lipid 
particles from several different patients, contained, in addition to apoB-100, small exchangeable 
apolipoproteins: apoA-I, apoE, ApoC-I, II, and III, apoM, apoD, and very small intensities of apoA-IV. 
ApoB-48 could not be recognized separately from apoB-100. The delipidated isolate of carotid artery 
extracellular lipid particles contained also components of the complement system. Complement components 
C3, C4b, and C9 were recognized in the delipidated protein component of the extracellular lipid particles. C3 
is a component of the alternative pathway, C4b belongs to the classical pathway, and C9 is a component of 
the membrane attact complex and they have been suggested/show to be important in atherosclerosis 
(Oksjoki, Kovanen, and Pentikainen, 2003). In an atherosclerosis model, modified LDL is found to induce 
C3 secretion from human THP-1 macrophages in vitro (Mogilenko et al., 2012). A complement component 
downstream of C3, C3a, has been found to induce secretion of monocyte chemoattractant protein -1, IL-6, 
and IL-8 from myofibroblasts in stenotic aortic valves (Helske et al., 2008). In addition to the complement 
components, the isolate contained also several immunoglobulin species. As these proteins had floated with 
the lipid particles, it is possible that they had been parts of both complement component-containing immune 
complexes (Ylä-Herttuala et al., 1994) or bound to components of the modified lipid particles (Torzewski 
and Bhakdi, 2013) These immune complexes are avidly taken up by macrophages, and, depending on the 
immunoglobulin species, they could stimulate immunocompetent cells (Mantovani, Rabinovitch, and 
Nussenzweig, 1972). 
Structural alterations of apolipoproteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
Figure 30 Circular dichroism analysis of the extracellular lipid particles and LDL. A. Direct 
apoB-100 -ELISA of LDL and the extracellular lipid particles, both 5 μg/ml in total protein content. 
The ELISA-analysis shows that apoB-100 is a prominent protein in the extracellular particles. B. The 
secondary structure of the apoB-100-containing extracellular lipid particles is dramatically different 
from the structure of plasma LDL. The change in α-helicality can be detected at 222 nm. 
BA 
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ApoB-100 of plasma LDL has in its native state α -helix, β-sheet, and random structures (Chen et al., 1987; 
Law et al., 1986; Scott et al., 1987), and there are two proteoglycan binding sites (aa 3359-3367 (site B) and 
aa 3147-3157 (site A) (Boren et al., 1998b), of which the former functions also as a LDL receptor-binding 
site (Boren et al., 1998a). Circular dichroism analysis of the carotid extracellular lipid particles indicated that 
the protein conformation of them was significantly different from that of LDL particles. Thus 35 % of apoB 
in LDL particles was found to be α-helical (Figure 30 A; Study III, Figure 2.), which is well in accordance 
with studies by Chen and co-workers, who reported the the α-helix content of apoB-100 of native LDL is 
approximately 40 % (Chen 1986). However, the α-helical content of the extracellular particle isolate was 
approximately only 4 % and the secondary structure of the proteins was almost totally deteriorated into 
random coil. Such result could be due to proteolytic degradation of the particles, but also lipolysis can affect 
the protein structure of apoB-100. Sneck and co-workers (Sneck et al., 2012) studied the effects of SMase 
and acid pH on the conformation of apoB-100, and their experiments showed that lipolysis by itself can 
significantly alter its conformational structure. They showed that apoB-100 lost most of its α-helical 
structure, which, actually, had transformed into β-sheets. In amyloid fibrils, the proteins lose their native 
conformation. The small exchangeable apolipoproteins, as well as apoB-100, are highly susceptible to 
amyloidogenesis due to their hydrophobic helix-content, and indeed, apoE, apoA-I, apoA-IV, apoC-II, and 
apoC-III have been reported to form amyloid fibril (Das and Gursky, 2015). ApoB-100 is very stable in its 
native state (Das and Gursky, 2015), but apoB-100 in electronegative LDL has been found to form amyloid 
fibrils (Parasassi et al., 2008). Also hydrolysis by PLA2 increases instability of apoB-100 in an experimental 
set up (Jayaraman, Gantz, and Gursky, 2011). Therefore it is not impossible that the extracellular particle 
isolate would contain amyloid, as apart from apoB-100, the extracellular lipid particle pool was found to 
contain several different apolipoproteins (apoE, apoC-I-III, and apoA-I) all of them having a high quantity α-
helical content. According to ELISA-analysis, apoB-100 it the most abundant protein component in the 
extracellular particle preparate (Figure 30 B). ApoB-100 is the most abundant protein, and it comprises 95 % 
of LDL protein (Karlsson et al., 2005), and it remains to be reliably shown that apoB-100 actually forms 
amyloid fibrils. Also the intracellular lipid droplets carry proteins on their surface, (Guo et al., 2009) some of 
which, such as several members of the PAT-protein family, are also α-helical by structure (Bickel, Tansey, 
and Welte, 2009), but, in the present study the proportion of intracellular lipid particle proteins was very low 
in the isolates from both aortic valves and from carotid arteries. Perilipin-2 was not detected from the 
stenotic aortic valves perilipin-2 with Western blot (Study II, Figure 4). When the extracellular lipid particles 
from the carotid arteries were analyzed, the mass protein spectrometry analysis did not detected any 
intracellular lipid droplet proteins among the first one hundred recognized proteins Study III, Supplemental 
Table I.  
Foam cells in the intima 
In order to study the effect of the extracellular lipid particles on foam cell formation, monocyte-derived 
primary human macrophages were treated with LDL, VLDL, cholesterol crystals and extracellular lipid 
particles isolated from human carotid artery plaques (Figure 30; Study III, Figure 6). The macrophages 
formed foam cells when treated with VLDL, cholesterol crystals, and extracellular lipid particles, however 
the lipid composition of the cells were different (Figure 31). The macrophages that had taken up cholesterol 
crystals were rich in CEs, while the cells that had taken up VLDL were rich in TAGs. Interestingly, the 
macrophages that had taken up extracellular lipid particles were enriched with TAGs and unesterified 
cholesterol over CEs, having similar lipid composition as the cells that had taken up VLDL. Interestingly, the 
lipid composition of the carotid extracellular lipid particles (Figure 22) seemed to be very different from that 
of VLDL (Figure 23). In this case one explanation would be lipid composition differences between different 
carotid artery donors and thus differences between different particle batches. 
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Macrophages take up oxidized lipoproteins avidly by receptors like CD36 (Endemann et al., 1993) or Lectin-
like Oxidized low-density lipoprotein receptor-1 (LOX-1)(Kume and Kita, 2001), and become lipid-filled 
foam cells. Oxidized LDL stimulates endothelial cells to produce MMP-1, a metalloprotease with a 
collagenase acitivity. MMP-1 promotes neovascularization of the atherosclerotic plaques, as the protease is 
able to clear a path for novel vasculature (Huang, Mironova, and Lopes-Virella, 1999; Huang et al., 2001). 
Oxidized LDL has also been shown to stimulate VEGF-production in monocytes, also a crucial factor in 
neovascularization (Inoue et al., 2001). In lysosomes of human leukemia cell line THP-1 cells oxidized LDL 
can inhibit CE hydrolysis, and thus accelerate accumulation of CE and free cholesterol in lysosomes of 
macrophages (Yancey and Jerome, 2001). Thus, uptake of oxLDL by macrophages results in lipid-filled 
macrophages, in which, insted of the cytoplasmic accumulation of CE-filled lipid droplets, CE also 
accumulates in the lysosomes. However, the relative proportion of lysosomal accumulation of CE strongly 
depends on the degree of LDL oxidation; thus, mildly oxidized LDL does not lead to significant lysosomal 
accumulation of CE or free cholesterol in macrophages. Murine macrophages metabolize oxidized LDL 
differently, in that oxidized LDL accumulates in mouse macrophages only transiently (Yancey and Jerome, 
2001). In mouse macrophages, oxidized LDL is known to activate the inflammasome (Duewell et al., 2010) 
and thus trigger the macrophages to secrete proinflammatory cytokines. 
While CEs accumulate in the foam cells, TAGs do not usually accumulate. In macrophages that have been 
isolated from atherosclerotic lesions, only 15 % of the neutral lipids is TAG (Mattsson et al., 1993). In 
hypoxia, however, β-oxidation in the macrophages decreases and accumulation of TAGs can occur (Boström 
et al., 2006). Hypoxia in the atherosclerotic plaque is, however, a transient stage, as neovessels grow in 
increasing numbers in the advanced stage plaques and provide oxygen to the hypoxic areas (Study I). In the 
TOF-SIMS analysis of the coronary artery sections (Study I), the spatial distribution of TAGs was found to 
differ from the spatial distribution of cholesterol and CEs, as TAGs were found near the endothelium or near 
the endothelia of the neovascular capillaries. From MS-images it was not possible to distinguish whether 
TAGs were on the luminal side of endothelial cells or whether they had crossed the endothelium. TAGs may 
have access to the intima with VLDL or VLDL-remnants, or in chylomicron-remnants. Lipoprotein particles 
smaller than 75 nm can enter the subendothelial space (Nordestgaard and Zilversmit, 1988) and the entrance 
can be enhanced through endothelial damage (Frank and Fogelman, 1989) by free fatty acids released by 
endothelial cell-associated LPL (Pentikäinen et al., 2002). 
Figure 31. Foam cell lipid content 
of human primary macrophages 
treated with LDL, VLDL, 
cholesterol crystals, and 
extracellular lipid particles. High 
concentration of unesterified 
cholesterol in the cells treated with 
cholesterol crystals is artefact from 
cholesterol crystals attached on the 
cells. 
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Inflammasome activation by extracellular lipid particles 
As cholesterols crystals are an established activator of NLRP3-inflammasome in human monocyte-derived 
macrophages (Rajamäki et al., 2010), we were prompted to test whether the estracellular lipid particles from 
human carotid artery lesions would also activate the inflammasome and, also by this way, be an initiating 
factor in atherosclerosis. The extracellular lipid particles were indeed found to induce IL-1β secretion from 
macrophages in vitro in human monocyte-derive macrophages that were primed with lipopolysaccharide 
(LPS) as a first stimulus. IL-1β, in turn, is capable in inducing SMase secretion from macrophages (Marathe 
1998). The mRNA-expression of NLRP3 pikes already at 1 hour incubation with cholesterol crystals in LPS-
primed cells. (Rajamäki et al., 2010). Interestingly, Rajamäki and co-workers showed that cholesterol 
crystals activate the IL-1β secretion slowly: the high point of cholesterol crystal-induced caspase-1 mRNA 
expression in LPS-primed cells is at 9 hour time point (Rajamäki et al., 2010). Slow production of IL-1β was 
also detected when the primary human monocyte-derived macrophages, or THP-1 cell-line macrophages, 
were treated with the extracellular lipid particles. Thus, an overnight incubation of the THP-1 cells in vitro 
was required for remarkable inflammasome activation, as measured by appearance of specs in the cells, and 
for IL-1β secretion. The IL-1β -secretion that was followed by macrophage incubation with the extracellular 
lipid particles was almost 2-fold compared with the activation by cholesterol crystals. While cholesterol 
crystals were detected in the extracellular lipid particles (Study III, Figure 3), the particles isolated also 
contained lipid droplets with features of modified lipoproteins, and thus the cytokine secretion was likely 
induced by the combination of several different activators. 
To find, which component of the extracellular lipid particles was the culprit for inflammasome activation, 
LDLwas treated with SMase, PLA2, and α-chymotrypsin, or oxidized by CuSO4 and thereafter incubated 
with or without LAL (Study III, Figure 5B). Only such LDL particles in which surface hydrolysis with PLA2 
was combined with the core hydrolysis with LAL, were able to induce IL-1? secretion that was at least as 
strong as activation with cholesterol crystals. Interestingly, and somewhat surprisingly, oxidized LDL did not 
trigger IL-1β secretion from human monocyte-derived macrophages, while in previous experiments by 
Duewell and co-workers in a mouse model, it was a strong activator of inflammasome (Duewell et al., 2010). 
None of the tested activators could induce IL-1? secretion without LPS-priming (Study III, Figure 5B). As 
NLRP3-inflammasome activation requires a two-step activation (Latz, Xiao, and Stutz, 2013), it suggests 
that none of the LDL hydrolysis products used for activation were able to prime the inflammasome 
activation pathway by themselves. On the contrary, the activation always needed a preceeding 
lipopolysaccharide-treatment as a priming step. 
To test, whether IL-1β -secretion was truly due to inflammasome activation, the effect of cytochalasin D and 
caspase-1-inhibitor Z-YVAD on IL-1β -secretion was examined (Study III, Figure 5D). Cytochalasin D 
prevents the uptake of modified lipid particles, and caspase-1 is inhibited with Z-YVAD, that prevents 
autoproteolysis of caspase-1 to mature caspase-1 and thus prevents IL-1? secretion from the cells (Guey et 
al., 2014). Both inhibitors were found to prevent IL-1β secretion from the primary monocyte-derived 
macrophages, which were stimulated with estracellular lipid particles and with LDL hydrolyzed with the 
combination of PLA2 and LAL. As caspase-1 proteolysis is triggered by NLRP3-inflammasome activation 
and the mature protease is required for IL-1β secretion, prevention of the IL-1β secretion with a caspase 
inhibitor suggests that the extracellular lipid particles do indeed activate the NLRP3 inflammasome. Also, 
uptake of the extracellular lipid particles appears to be required for activation of the inflammasome in 
macrophages.  
One component of the extracellular matrix, cholesterol crystals, has been shown to be a potent activator of 
inflammasome both in murine models and in human macrophages (Duewell et al., 2010; Rajamäki et al., 
71 
 
2010). In Study III, the extracellular lipid particles isolated from carotid arteries were shown to induce 
inflammasome activation inflammasome in primary human monocyte-derived macrophages in vitro. As the 
accumulated lipid particles in the aortic valves closely resembled the particles isolated from the carotid 
arteries in their lipid composition, size distribution, and protein composition, it could be expected that similar 
phenomena, such as lipolysis, proteolysis, and oxidation of the retained lipoproteins would take place in both 
tissues. Both cholesterol crystals (Rajamäki et al., 2010) and calcium crystals (Wen et al., 2013) have been 
found to activate the inflammasome and thus increase the severity of atherosclerosis, and, moreover, 
inflammasome activation has been also shown to increase calcific nodule formation in smooth muscle cells 
(Wen et al., 2013). Taken together, not only cholesterol crystals, but also the lipoproteins that have been 
lipolyzed with PLA2 and LAL can activate the inflammasome and thus induce macrophages to produce IL-
1?. On the other hand, SMase or proteolysis with α-chymotrypsin alone or in combination with LAL did not 
produce an inflammasome activation to a similar extent. The most potent activator of inflammasome in 
human atherosclerotic lesions and the exact mechanism of such activation are still to be recognized.  
  
72 
 
Concluding remarks 
The aims of this thesis were to examine how the lipids, such as are known to take place in the atherosclerotic 
intima, are spatially arranged in various phases of atherosclerosis, to image the lipid particles and cholesterol 
crystals, to isolate and characterize lipids from the extracellular compartment of aortic valve and 
atherosclerotic arteries with various state-of-the-art methods, and to examine whether the extracellular lipid 
particles affect inflammation and cytokine relase in cells relevant for atherosclerosis. 
1. The lipids in the coronary arteries were found to be spatially arranged in the intima. In normal intima the 
detected lipids are cell plasma membrane lipids that consist of phospholipids and unesterified cholesterol. In 
the atheroma-stage and in the advanced-type lesions of atherosclerosis, most of the lipid was composed of 
CEs and unesterified cholesterol, which lipids accumulated deep in the intima. Interestingly, TAGs were 
very seldom found to co-localize with cholesterol of either type, rather they localized only periendothelially 
either near the luminal endothelium or near the endothelia of neovascular microvessels. The differential 
spatial arrangement of the lipids start already in the fatty streak stage and it was the most prominent in the 
distributions of cholesterol and TAGs. The newly introduced ratio of two cholesterol ions (385/369) provides 
a way to distinguish signals of esterified cholesterol from unesterified cholesterol even if the molecular ions 
have fractured in the analysis. 
2. The extracellular lipid particles were isolated and characterized. The lipid composition of the lipid 
particles isolated from either aortic valves or from atherosclerotic arterial intima was different from plasma 
lipoproteins. Free fatty acid contents were increased, as was the proportion of unesterified cholesterolThe 
proportion of PC was decreased comparet to plasma LDL. This degradation of the surface and core lipids of 
the lipid particles was most likely due to action of both lipolytic and proteolytic enzymes. The extracellular 
lipid particles were found to contain several apolipoproteins, such as apoB-100, which was the main protein, 
and also apoE, apoC-I, II, and III, and apoA-I and IV. Also components of complement and 
immunoglobulins were found. The conformation of the protein moiety of the lipid particles was dramatically 
different from that of the plasma lipoproteins, as the α-helix-content and organized secondary structure of the 
proteins were only fraction of that found in plasma lipoproteins. In stenotic aortic valves, lipid composition 
had remarkable individual differences between the patients. Similar individual differences in should be 
analyzed from the carotid artery plaques. These individual differences in lipid composition would perhaps 
partly expain also why atherosclerotic plaques develop into stable or unstable plaques. 
3. The extracellular lipid compartment isa component of atherosclerosis which actively contributes to 
inflammation. The extracellular lipid is composed of lipoprotein-derived lipid particles that have been 
modified by lipolytic and proteolytic enzymes. Also a minor proportion of apoptotic foam cell-derived lipid 
droplets can be found extracellularly. In vitro cholesterol crystals can be generated from LDL and VLDL a 
result from weakening the surface and hydrolysing the core lipids. The unesterified cholesterol derived from 
the extracellular lipid particles canserve as a source of cholesterol crystals. These crystals combined to the 
lipid particles are able to activate a multiprotein complex called the inflammasome, to produce pro-
inflammatory cytokines, such as IL-1β. In addition to the crystals, other possible components of lipid 
particles that are contributing to activation of the inflammasome. The most potent activation was 
experimentally archieved by phospholipid hydrolysis products LPCs and free fatty acids, but the overall 
activation is likely resulted from a combination of modifications. 
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Figure 32. The extracellular lipid particles, their accumulation, and their effects. Plasma LDL 
enters the intima, attaches to the extracellular matrix proteoglycans, and accumulates near the 
internal elastic lamina. The retained LDL is modified by lipolytic and proteolytic enzymes, and by 
oxidation, and is subsequently aggregated and fused, with ensuing formation of extracellular lipid 
particles, and the cholesterol in in these particles is crystallized. The extracellular lipid particles and 
crystals are taken up by macrophages which induces inflammasome activation and the cells produce 
inflammatory cytokines.  
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